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INTRODUCTION 
Nosocomial (hospital-acquired) pneumonia (HAP) 
continues to be an important cause of morbidity and 
mortality in the hospital. HAP is the third most common 
nosocomial infection after urinary tract and surgical wound 
infections (13). In addition, HAP is the nosocomial 
infection with the highest mortality rate (93). These 
infections are often difficult to treat, because most are 
caused by Gram-negative bacilli (GNB) that may be highly 
resistant to antimicrobial agents (12). HAPs frequently 
occur in intensive care patients with underlying lung 
and/or systemic diseases (45,39). Many patients are 
intubated and are on assisted ventilation. Several sources 
of infection associated with ventilators or respirators have 
been described in the past. Most of these sources have been 
eliminated by improvement in techniques used in the 
disinfection and cleaning of ventilator equipment (25). 
Today, the focus of concern is microbial contamination of 
the breathing circuit of the ventilator (90). The Centers 
for Disease Control (CDC) recommend that the ventilator 
breathing circuits be changed every 24 hours. The very 
limited epidemiological and microbiological data from one 
medical center (17,20) demonstrate that it may not be 
1 
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necessary to change these circuits as often as every 24 
hours. However, before changing this conservative 
recommendation, more data are needed to establish the 
safety of changing circuits at longer intervals. The 
approximate cost of the ventilator circuit is $15. It is 
estimated that changing ventilator breathing circuits at 48 
hours rather than 24 hours would amount to $50,000 per year 
in savings at the Medical College of Virginia. On a 
national scale the savings would amount to millions of 
dollars. 
Most patients who are placed on ventilatory assistance 
are supported by continuous volume respirators (Fig. 1). 
Air is humidified when it is passed through a cascade, or 
wick humidifier. After passage through the humidifier, the 
gases are delivered to the patient by the inspiratory tubing 
in the breathing circuit. The inspiratory tubing is 
connected to the endotracheal tube of the patient by a Y-
connector and swivel adaptor. Expired gases from the 
patient are conducted away by the expiratory tubing which 
connects to the other limb of the Y-connector. Condensate 
frequently collects in the respiratory breathing circuit. 
The warm moist environment of the respiratory circuit is 
conducive to growth of any microorganisms that may enter the 
circuit. When the respiratory circuit is contaminated with 
microorganisms, there is the potential for delivery of 
bacteria or fungi to the patient's lower respiratory tract. 
Whether or not infection takes place is determined by one or 
a combination of several factors including the virulence of 
3 
the organisms, the size of the inoculum, the presence of 
foreign bodies in the respiratory tract and the status 
of host defenses. 
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Figure 1. Patient on mechanical ventilation. 
LITERATURE REVIEW 
Normal Lung Anatomy 
The tracheobronchial tree of humans consists of the 
trachea, bronchi,and bronchioles. The main bronchus is 
subdivided into two branches known as the nonrespiratory 
bronchioles. From these bronchioles branch the terminal 
bronchioles and respiratory bronchioles. Distal to the 
terminal bronchioles are the alveoli, where oxygen and CO 
2 
exchange takes place. 
Normal Host Defenses 
Humans are provided with a variety of non-specific 
defenses against invasion of the lungs by foreign particles. 
First, the size of the particle determines where it will be 
deposited (87,64). The aerodynamic defenses of the 
respiratory tract remove particulate matter from the 
airstream by impaction or sedimentation. In the nose this 
process begins with filtration by the nasal hairs of very 
large particles (10-20u in size). These particles will 
impact on the surfaces of the nasal septum and turbinates. 
As the airstream then changes direction at the nasopharynx, 
particles of approximately lOu in size will impact on the 
posterior wall of the pharynx. The airway above the vocal 
cords is narrow and irregular, creating turbulence and 
5 
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forcing both large and smaller particles onto the 
mucociliary blanket which lines the tracheobronchial tree. 
This blanket which extends from the nasopharynx to the 
terminal bronchioles rests on the cilia of the respiratory 
epithelial cells. Each epithelial cell is laden with 
approximately 200 cilia. The upward movement of the 
respiratory cilia (more than 14 times per second) sweeps the 
overlying mucus blanket towards the oropharynx where the 
mucus and its entrapped material are swallowed or 
expectorated. 
Below the vocal cords, sedimentation, which removes 
most particles of 5.0 u to 0.2 u, becomes more important 
than impaction. The airstream velocity slows as it enters 
the progressive bifurcations of the tracheobronchial tree. 
Larger particles are removed in the more proximal bronchial 
tree, and smaller ones may reach the peripheral airways 
before being deposited onto the mucociliary blanket. A few 
of these small particles can settle in the lower respiratory 
tract. Particles smaller than 0.1 u are distributed 
randomly throughout the airways by their brownian motion, 
and most of them are exhaled (3,66). 
In the air exchange units other components of the host 
defenses become important. The substances lining the alveoli 
include surfactant, iron-containing proteins (transferrin), 
IgG, opsonins and properdin (78). Surfactant is a substance 
secreted by alveolar cells into the alveoli which reduces 
the surface tension. The remaining substances are present 
in the blood. Transferrin is important in the transport of 
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iron, IgG is an immunoglobulin fraction which contains 
antibodies, opsonins prepare bacteria for phagocytosis and 
properdin is a nonspecific antibody-like substance that 
kills bacteria and viruses and lyses certain red blood 
cells. 
The airway reflexes are an important adjunct to the 
other defenses of the respiratory tract. The cough removes 
excessive secretions and foreign materials from the 
tracheobronchial tree. Bronchoconstriction prevents or 
reduces penetration of inhaled materials into the distal 
areas of the respiratory tract. 
Several local factors inhibit adherence of GNB. Oral 
secretions contain IgA antibody which has been shown to coat 
various bacteria and prevent their adherence (102). The 
adherence of GNB to epithelial cells of the oropharynx is 
due to an alteration of the cells' receptors (66,104). Woods 
and associates have shown that the host alterations 
associated with increased susceptibility to Pseudomonas 
§§£U£.ii]osa colonization are due to the loss of fibronectin 
from the cell surface. They examined buccal epithelial 
cells from 12 seriously ill patients who were colonized with 
Ei §§EU£iD2§§ and from uncolonized controls. They found that 
the presence of fibronectin prevented adherence of GNB. The 
function of fibronectin in the lung is uncertain (78). 
Fibronectin is an adhesive substance secreted by alveolar 
macrophages which also coats microorganisms and facilitates 
attachment to phagocytic cells. 
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In addition, the oropharynx contains a large and 
complex resident bacterial flora. These normal microflora 
are acquired shortly after birth and remain constant over 
time in a given individual, but often differ among 
individuals. Although the upper respiratory tract is bathed 
with secretions which are in constant motion in the 
oropharynx, the resident bacterial flora is not disturbed 
(104). It has been found that the microbial composition of 
a region is determined by the relative abilities of the 
individual species to attach to the epithelial cells of that 
region (32). Organisms which are unable to attach to the 
cell surfaces are removed by secretions and thus fail to 
colonize mucosal surfaces. Gram-negative bacteria are 
unusual pharyngeal isolates in normal humans. The normal 
oral defenses against GNB are highly effective and seem to 
involve both physical clearance and local bactericidal 
activity. LaForce (51) studied the elimination of GNB from 
the mouth of individuals after gargle challenge. 
8 
Suspensions of GNB (10 organisms per ml) were gargled by 
normal volunteers, and then pharyngeal cultures were taken 
over a period of time. Suspensions of Escherichia colix 
Klebsiella pneumoniae and Proteus mirabi1 is were used. 
Bacterial counts rapidly decreased and less than IX of the 
original inoculum was recovered after three hours. Using 
piliated and nonpiliated strains of liColi, LaForce 
demonstrated that GNB do not adhere well to normal buccal 
epithelial cells unless the GNB are piliated. Stevens et al 
(95) also demonstrated in vitro that meningococci with pili 
9 
consistently attach to human nasopharyngeal cells in greater 
numbers than meningococci without pili. 
Pathophysiology of Hospital Acquired Pneumonia 
Microorganisms that cause Hospital Acguired Pneumonia 
Data from the National Nosocomial Infection Study 
(NNIS) of the CDC indicated that the majority of hospital 
acquired pneumonias were caused by GNB. NNIS is an ongoing 
study of nosocomial infections among 51 national hospitals. 
Ei aeruginosa was the most common causative microorganism 
followed by Staphylococcus aureus and Klebsiella (14). The 
pathogen most frequently associated with HAPs on all 
services was PA aeruginosa. SA aureus was the second most 
common pathogen on all but the Gynecology and Newborn 
services (14). A recent prospective study by Bartlett and 
colleagues (6) examined HAP in 159 patients during a 42-
month study period. Bacteriological studies were limited to 
transtracheal aspirates, pleural fluid and blood cultures. 
Gram-negative bacilli were the causative agent in 46%. The 
predominant microorganisms in this survey were Klebsiella 
§Ei(23S>) . 
LaForce stated "that the frequency with which GNB cause 
HAP is due to 1) the ease with which these microorganisms 
are recovered from culture; 2) the fact that these 
microorganisms are ubiquitous in intensive care units (and 
also are capable of becoming resistant to commonly used 
antibiotics); and 3) the ease with which these bacteria 
10 
colonize the oropharynx in ill persons" (52). 
Routes of Infection 
According to Levison, pathogens "reach the lung by one 
of five mechanisms: 1)inhalation of small airborne 
particles; 2) aspiration of resident naso-oropharyngeal 
flora or large airborne infectious particles after 
deposition in the naso-oropharynx; 3) hematogenous spread of 
particles to the lung from another site of infection; 4) 
direct extension of bacteria from a contiguous site of 
infection; or 5) exogenous penetration and contamination of 
lung parenchyma by bacteria" (55). The aerogenic routes of 
inhalation and aspiration are the most common mechanisms. 
Several studies have shown normally that the airways 
below the vocal cords are sterile. In a study of 100 
patients, Potter and associates (73) collected expectorated 
sputa, pharyngeal cultures and cultures from the trachea and 
mainstem bronchi during bronchoscopy. Only one patient 
yielded a potential respiratory pathogen from bronchial 
cultures. Lees examined 42 patients and found all bronchial 
secretions from "normal people" to be sterile (54). Pierce 
and Sanford (72) stated that only 2% of normal persons are 
at risk for developing pneumonia due to GNB, because the 
oropharynx does not provide a suitable environment for the 
growth of GNB. In Johanson's study (45) of colonization in 
hospitalized groups of patients, 25% of the colonized 
patients developed pneumonitis as compared to only 3% of 
those patients who were not colonized. The latter study 
indicated that the pharyngeal clearance of GNB is impaired 
11 
in ill patients. 
Oropharyngeal Colonization 
Colonization of the upper respiratory tract with GNB 
normally occurs in only 2% to 18% of healthy subjects. In 
1969, Johanson and coworkers (45) demonstrated that the 
prevalence of colonization increased as the severity of 
illness increased in a study of 230 patients from five 
groups of adults: nonhospital-associated normal subjects; 
hospital-associated normal subjects; physically normal 
hospitalized patients; moderately ill hospitalized patients; 
and moribund patients. Oropharyngeal cultures were obtained 
from all subjects. Prevalence rates of colonization with GNB 
were markedly increased in the moderately ill and moribund 
patients. Johanson suggested that the increased prevalence 
of GNB might have been the result either of increased 
exposure to GNB or a diminished capacity to clear such 
organisms from the pharynx. In 1972, Johanson and 
associates (46) performed a prospective study of 213 
patients in a medical intensive care unit, and 45% of them 
became colonized (mostly with GNB) during the first four 
days of hospitalization (22% on the first hospital day). 
Nosocomial respiratory infections developed in 12.2% of the 
patients. Pneumonia occurred in 23% of the colonized 
patients compared to 3.3% of the noncolonized patients . The 
presence of coma, hypotension, expectoration of sputum, the 
use of endotracheal intubation, treatment with antibiotics, 
acidosis, azotemia, and either leukocytosis or leukopenia 
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was significantly associated with colonization. There was 
no consistent influence of diet on colonization. Of the 95 
patients who became colonized with GNB, 59% were taking 
solid food, 7* only liquids and 34% were receiving nothing 
by mouth. There appeared to be no difference in the 
invasiveness of the bacterial species. K.. ES§US20±§§x Ei 
a§ry^iD°§§A co1i and species of Enterobacter were the 
most commonly isolated organisms. In a prospective study of 
149 patients by Tillotson and Finland, 25% of 88 colonized 
patients developed nosocomial infection (98). Most were 
due to colonizing GNB. In another study of 34 intensive care 
unit patients, Johanson and colleagues (47) observed that 
53% of the patients were colonized with GNB. He suggested 
that epithelial cells of the upper respiratory tract contain 
binding sites (receptors) for GNB and that factors 
associated with serious illness appear to increase the 
availability of these binding sites. Such colonization by 
GNB appeared to precede the development of pneumonia. 
Johanson et al's observation that colonization 
occurred during the first few hospital days (46) suggested 
to Pierce and Sanford that there is a "susceptible pool" of 
patients in the hospital who are particularly predisposed to 
colonization (72). The concept of a susceptible pool was 
further supported by another study by Johanson and coworkers 
when they found colonization rates due to GNB of 35% in 
moderately ill hospitalized patients and of 73% in moribund 
hospitalized patients (45). Valenti and coworkers (99) 
performed throat culture surveys on persons over 65 years of 
13 
age who were living independently in apartments and elderly 
hospitalized persons. Nine percent of the oropharyngeal 
cultures from the first group were culture positive for GNB, 
and 60% of cultures from patients in the hospital were 
positive for GNB. Multivariate analysis suggested that the 
presence of respiratory disease and a bedridden existence 
were the two most important variables in predicting 
colonization. Factors not significantly associated with 
oropharyngeal colonization included age, mental status, 
bowel incontinence, poor dental hygiene, the presence of 
dentures, cigarette smoking or functional limitations due to 
diabetes, neurologic disease or collagen vascular disease. 
There also are some specific clinical conditions which 
may predispose a person to colonization by GNB. Mackowiak 
et al (56) demonstrated that alcoholics and diabetics have 
colonization rates with aerobic GNB of 35% and 36%, 
respectively. Niederman and colleagues (69) suggested a 
relationship between nutritional status and colonization. 
They observed a relationship between nutritional status and 
both tracheal cell adherence and colonization of the lower 
airways. Greater degrees of nutritional impairment based on 
the prognostic nutritional index were associated with higher 
levels of tracheal cell adherence than was observed in 
patients who had less nutritional depletion. They noted less 
binding of E§§udomonas to tracheal epithelial cells when 
they improved the caloric intake of patients with chronic 
tracheostomies. 
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The patients in intensive care units (ICUs) are at 
markedly increased risk for HAP. Johanson reported (47) a 
colonization rate of 22% on the first day of hospitalization 
in medical ICU patients. The colonization rate rose sharply 
over the first four days in the unit, then leveled off to a 
rate of 45%. Rose and Babcock (82) cultured multiple body 
sites of 64 patients admitted to a medical ICU and 85 
patients admitted to a surgical ICU to determine the 
frequency of colonization with GNB. Sites cultured included 
oropharynx, rectum, urethral catheters, endotracheal or 
tracheostomy tubes, nasogastric tubes, nasal oxygen 
cannulae, and several other types of less commonly used 
tubes. The pharyngeal carrier rate among the surgical 
patients increased by a total of 34 strains of GNB compared 
to 14 strains among medical patients. The authors 
interpreted this to mean that surgical patients carried more 
GNB because they had more tubes, and thus had a larger 
reservoir of GNB available for pharyngeal colonization. The 
most frequently recovered organisms were colijL 
Klebsiella^ EnterobacterA SerratiPseudomonas and Proteus. 
Also the administration of antibiotics may be related 
to the colonization of the respiratory tract. Johanson and 
his associates (46) provided evidence for this relationship 
in their study of 213 medical ICU patients. Antimicrobial 
drugs were administered to 50 of the 213 patients (23.4%). 
The authors studied a subset of 38 patients and obtained 
cultures before, during and after antimicrobial therapy. 
They noted colonization by GNB in 21/38 patients (55%) 
15 
before therapy and in 30/38 patients (79%) during or after 
therapy. They suggested that antimicrobial agents may have 
increased the rate of colonization, but pointed out that 
there was a high level of colonization before therapy. 
Major surgery also may influence colonization of the 
oropharynx. Johanson et al (48) demonstrated that following 
major surgery, there was an increased adherence of GNB to 
14 
squamous buccal cells. They studied the adherence of C-
labeled P.. §§ruginosax gneumon iax col i and 
mirabilis to buccal squamous cells of 32 noncolonized 
patients undergoing elective surgery. Buccal mucosal cells 
were taken from patients both pre- and post-surgically. The 
IS vitro test results were correlated with the in vivo 
occurrence of bacillary colonization. Preoperatively, the 
mean adherence was 4.3 bacilli/cell and postoperatively it 
was greater than 8.3 bacilli/cell. Sixty-nine percent of 
the 16 patients in the postoperative group with adherence of 
greater than 8.3 bacilli/cell became colonized with GNB, 
whereas none of the 16 patients with adherence of less than 
8.3 bacilli/cell postoperatively became colonized. 
Raman et al. (75) suggested that there may be a 
constituent present in smoker's saliva that is responsible 
for increased adherence of organisms. Using an in vitro 
assay, they examined the buccal epithelial cells of smokers, 
nonsmokers and exsmokers for adherence of Streptococcus 
pneumoniae. The background counts using cells washed with 
phosphate buffered saline in the three groups were similar. 
16 
Smokers had a markedly increased pneumococcal adherence 
(p<0.001). The authors also noted significantly increased 
(p<0.001) adherence of the bacteria to cells of nonsmokers 
when they were incubated with the saliva of smokers. 
Gastric Colonization and Amplification 
duMoulin and coworkers (28) studied the gastric and 
upper-airway flora of 60 patients from a respiratory-
surgical ICU who were treated with antacids or cimetidine. 
In 87% of the patients, one or more organisms were cultured 
simultaneously from the upper airway and stomach. A 
sequence of transmission was demonstrated in 17 of these 
patients. In 11 patients, the upper-airway colonization 
occurred after the organism first appeared in the stomach. 
Pneumonia due to GNB occurred in 31 of these patients(52*). 
No pneumonia developed in the eight patients whose gastric 
and upper-airway flora differed. The pH of the fluid 
correlated positively with the concentration of GNB in 
gastric fluid. The authors concluded that maintenance of 
high gastric pH led to increasing concentrations of GNB in 
the stomach. Atherton and White (5) studied 10 adults on 
ventilatory support who had paralytic ileus. There was 
microbial overgrowth of GNB in the stomach of 9 patients. 
In 6 patients, the bacteria multiplying in the stomach 
corresponded with those found in the trachea. In 3 
patients, the organism first appeared in the gastric 
contents. These studies demonstrated that overgrowth of 
bacteria in the stomach may provide a reservoir for 
colonization of the esophagus, mouth, nasopharynx and 
17 
trachea. 
Intubation of the Respiratory Tract 
Patients who require ventilatory support are always 
intubated or have a tracheostomy. Endotracheal tubes can be 
introduced through the nares (i.e.,nasotracheal tube) or 
through the mouth (i.e.,orotracheal tube). A tracheostomy 
is a surgical opening into the trachea through which a 
tracheostomy tube is inserted. Nasotracheal and orotracheal 
tubes generally are used on patients who require short-term 
ventilation. Patients on prolonged ventilation or with 
secretion problems generally require tracheostomies. All 
tubes inserted into the trachea are surrounded by a cuff 
which may be inflated. Inflation of the cuff (balloon) 
occludes the trachea around the tubes to prevent aspiration. 
Although inflation of the endotracheal tube cuff prevents 
aspiration of large volumes of gastric content or 
oropharyngeal secretions, very small quantities of 
oropharyngeal secretions still may be aspirated (48). This 
was substantiated by Macrae and colleagues (58) who studied 
a patient after resection of the middle third of the 
esophagus. Barium was instilled into the upper esophagus to 
evaluate the anastomosis. Chest X-ray showed that barium 
had spilled over into the oropharynx and tracked around the 
folds of the inflated cuff into the trachea and the left 
main bronchus. Patients requiring artificial airways are 
predisposed to HAPs because these tubes bypass the upper 
airway defense mechanisms and preclude effective coughing. 
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In 1981, Cross and Roup (22) studied 13,086 patients 
prospectively over 11 months for the development of HAP. Of 
these, 814 patients had intubation or intubation plus 
ventilation for at least 24 hours. Fifty-nine of the 814 
patients {1.2%) developed pneumonia. Twelve of these (1*) 
occurred in patients with endotracheal tubes who were 
ventilated and 10 (1%) occurred in patients with 
tracheostomies and ventilation. Thirteen HAPs (1.6%) 
occurred in persons who had only tracheostomies. One case 
(0.1*) occurred in a patient who had only an endotracheal 
tube, and twenty-three (2.8%) occurred in patients who had 
an endotracheal tube and either intermittent positive 
pressure ventilation or nasal oxygen therapy. 
In 1985, Sanderson (85) examined 37 intubated patients 
( most of whom were surgical patients) to determine whether 
or not pharyngeal bacteria were carried into the trachea 
during intubation. Pre-intubation pharyngeal swabs were 
taken, and pre- and post-operative tracheal aspirates were 
obtained with a sterile catheter introduced through the 
endotracheal tube. Thirteen (38%) of the tracheal samples 
taken post-operatively revealed potential pathogens 
(Hemophilus influenzae;,. pneumoniae, coliforms and S.. 
§UI§y§)• In each case the organisms had also been isolated 
from the pharyngeal swab taken prior to intubation. This 
illustrated the frequency with which organisms could be 
introduced to the respiratory passages by intubation," even 
when carried out without difficulty." Mehta ( 61) studied 
90 patients undergoing surgery during endotracheal 
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anaesthesia. He placed 20 ml of contrast medium on the 
back of the tongue in patients lying supine on the operating 
table after obtaining an airtight seal in the trachea by 
inflating the cuff of the endotracheal tube. In 18 patients 
contrast medium passed through the larynx and accumulated in 
the trachea above the inflated cuff, and entered the lungs 
at the end of the operation when the cuff was deflated. 
Dixon cites two ways in which persons with artificial 
airways may aspirate oropharyngeal flora (25). Persons with 
such devices are unable to clear their oral secretions 
effectively, and those secretions collect in the posterior 
pharynx. Even when oropharyngeal suctioning is performed 
effectively, the pooled secretions enter the 
tracheobronchial tree whenever the cuff is deflated. 
Evidence that pooled respiratory secretions may be the 
source of microorganisms that enter the tracheobronchial 
tree in intubated patients was provided by Schwartz and 
associates (89). They observed that many isolates of 
bacteria recovered from endotracheal tubes, particularly 
Enterobacteriaceae, had been recovered in prior cultures 
from the hypopharynx. Spray (92) also noted that these 
pooled respiratory secretions above the tube cuff are 
heavily colonized with bacteria. Every four hours, she 
placed Evan's blue dye on the tongues of one hundred medical 
and surgical patients with endotracheal tubes. If blue dye 
was obtained on suctioning, it was considered evidence for 
aspiration. Aspiration was detected in 40 of the 100 
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patients an average of 14 hours after placement of the dye 
on the tongue. Also according to Dixon, the presence of the 
airway itself reduces the effectiveness of local 
tracheobronchial defense mechanisms through local trauma and 
drying (25). 
Aspiration 
Aspiration of oropharyngeal secretions is probably the 
most important mechanism by which pneumonia develops. 
However, pneumonia also may occur as a consequence of 
inhalation of small airborne particles. Aspiration takes 
place when fluid in the oropharynx passes into the lower 
tracheobronchial tree during respiration. Aspiration may be 
followed by no adverse effects or it may result in damage to 
the lung parenchyma. When fluid is aspirated, it may carry 
microorganisms into the lower respiratory tract. The 
macrophage constitutes the principal cellular defense of the 
alveolus. There is about one cell per three to four 
alveoli. In most instances, bacteria are inactivated by 
these cells. When aspiration takes place with a large 
bacterial inoculum or with a particularly virulent 
microorganism, the respiratory macrophages may be 
overwhelmed (78). A second line of cellular defense is 
constituted by the polymorphonuclear leukocytes. They are 
located in capillaries in the interstitial space. They 
migrate to the alveoli in response to a chemotactic 
stimulus. Chemotactic factors are produced by alveolar 
macrophages and by activation of the alternate complement 
pathway by bacterial endotoxins. Green and Kass (34) 
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aerosolized labeled bacteria (p32-tagged staphylococci) into 
the lungs of mice and immediately sacrificed the animals and 
examined the lungs histologically. The authors demonstrated 
that bacteria do not remain on the alveolar surface, but 
within minutes are almost all ingested by macrophages 
without histologic evidence of an inflammatory response. 
They repeated the experiment with Gram-negative organisms 
and demonstrated that ingestion takes place more slowly with 
these organisms. 
Several studies show that nonintubated normal and ill 
adults may aspirate during sleep. In 1929, Quinn and Meyer 
(74) demonstrated aspiration in 5 of 11 sleeping patients 
after instillation of iodized oil into their noses. A 
chest X-ray taken in the morning identified the oil in small 
quantities in both lower lobe bronchi. Based on these 
observations, the authors stated that aspiration of 
infective material also might be possible. In 1953, Amberson 
introduced iodized oil into the mouth of sleeping patients. 
Chest X-ray the following morning revealed the oil in the 
lungs of some of the adults (unpublished study by 
J.B.Amberson, cited in 103). In a study of 8 patients, 
Winfield and coworkers (103) attempted to reproduce the 
earlier experiments by injecting 2-3 ml of contrast material 
into the posterior nasopharynx during sleep. However, they 
were unable to confirm the earlier work as in no instance 
was the opaque medium visible in the lungs or trachea on 
chest X-ray the next morning. On the other hand, by 
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injecting indium chloride into the posterior nasopharynx 
of twenty normal subjects and ten patients with depressed 
consciousness, Huxley and colleagues (43) were able to 
demonstrate the occurrence of aspiration. The thorax of all 
subjects was scanned within 4 hours of completing the 
posterior pharyngeal injections with radioactive tracer. 
Forty-five percent of the normal subjects aspirated during 
deep sleep and aspiration was observed in 70% of the 
patients with depressed consciousness. 
The rare occurrence of pneumonia following aspiration 
is evidence of the lung's remarkably efficient and effective 
clearance mechanisms. If, however, the aspirated inoculum 
is large or contains virulent bacteria, the clearance 
mechanisms may be overcome. In 1972, Bryant et al (8) 
studied the bacterial colonization profile of the patient 
with tracheal intubation undergoing mechanical ventilation. 
The author examined serial tracheal cultures of 129 patients 
who required tracheal intubation for greater than 48 hours. 
Tracheal cultures became positive for pathogens in 115 
patients (89%). Although the initial cultures often 
demonstrated normal flora of the upper respiratory tract, 
within a few days pathogens (E§eudomonasA Klebsiella^ 
Proteusx Candida^ and aureus^ etc.) displaced the normal 
flora. The author noted that, frequently, one pathogen 
replaced another, and 43% of the patients became colonized 
with two or more GNB. Tracheobronchitis occurred in 31 
patients, 47 had pneumonitis, and 28 developed colonization 
without evidence of respiratory infection. 
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Removal of Respiratory Secretions with Suction Catheters 
An additional risk factor for HAP is the introduction 
of suction catheters into artificial airways to remove 
respiratory secretions. Demers stated that there were three 
adverse effects of suctioning. This repeated procedure 
predisposes the patients to pneumonia by: 1) direct injury 
to the endobronchial mucosa; 2)by inducing hypoxemia; and 3) 
by causing atelectasis (24). In addition if aseptic 
technique is not practiced, bacteria can be introduced into 
the lower respiratory tract. 
Epidemiology 
Definition of Hospital Acguired Pneumonia 
Hospital acquired pneumonias are defined as those 
respiratory infections that develop in hospitalized patients 
in whom the infection was neither present nor incubating at 
the time of admission (11). These infections usually are 
not manifest in the first 48 hours of hospitalization. They 
occur as a result of the introduction of. microorganisms into 
the lungs during hospitalization. Pneumonia often is 
difficult to diagnose. Johanson (45) classified infections 
as "definite" or "probable". A diagnosis of "definite" 
infection required the presence of all four determinants: 
1) the appearance of a new or progressive infiltrate on 
chest X-ray; 2) fever; 3)leukocytosis; and 4)purulent 
tracheobronchial secretions. A diagnosis of "probable" 
infection was based on 3 criteria: 1) fever; 2)leukocytosis; 
and 3) either a new or progressive pulmonary infiltrate on 
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chest X-ray or the presence of purulent secretions. Results 
of cultures were not used . In their review, Crane and 
Lerner (16) relied on bacterial isolation from sputum for 
definite diagnosis of pneumonia. They required: l)isolation 
of the same predominant bacteria from two or more 
consecutive sputum cultures; or 2) isolation in close 
temporal proximity of the same species from blood and 
sputum; or 3) isolation of appropriate bacteria from pleural 
fluid. The definition for the diagnosis of HAP used by NNIS 
of the CDC requires purulent sputum production more than 48 
hours after admission in a patient with no evidence of prior 
pulmonary infection or increased production of purulent 
sputum with reappearance of fever in a patient admitted with 
pulmonary disease. In addition, there must be one of the 
following: 1) an infiltrate on chest X-ray; 2) char­
acteristic clinical manifestations of pneumonia; or 3) the 
patient must have cough, fever or pleuritic chest pain. 
The most precise published criteria for HAP are those 
oi -raven and colleagues (20). These include 1) purulent 
atum with a Gram stain having greater than 25 leukocytes 
and less than 10 squamous epithelial cells per high power 
field; 2) a significant respiratory or nosocomial pathogen 
isolated from sputum cultures and/or bacteria seen on Gram 
stained smears of the sputum; 3) a peripheral leukocyte 
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count of greater than 10,000 per mm ;4) fever of greater 
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than 100.4 F; and 5)a new and persistent infiltrate on chest 
X-ray. Garibaldi and coworkers (30) used fever, purulent 
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sputum, clinical findings and abnormalities on chest X-ray 
to define HAP (30). They used three categories for HAP. 
Patients with microbiologically proven pneumonia were 
categorized as Class 1. Patients were placed in Class 2 
when they had clinical evidence of pneumonia without 
microbiologic confirmation. Pneumonia was categorized as 
Class 3 when patients had fever, purulent sputum, or 
suggestive chest X-rays. In Sanford's opinion, the CDC 
definition should be employed "unless there are specific 
justifications in a study for not doing so" (85). 
Diagnosis of Hospital Acquired Pneumonia 
Respiratory secretions obtained as a coughed sputum 
specimen are frequently contaminated by oropharyngeal flora 
which may obscure the identity of the causative agent. 
Numerous studies have demonstrated the discrepancy between 
cultures of sputum and pathogens present in the lower 
respiratory tract (6,23). In a bacteriologic study of 
respiratory secretions obtained by transtracheal aspiration 
from 488 patients, Bartlett (6) studied the diagnostic 
accuracy of cultures obtained by this technique when 
compared with clinical parameters and final diagnosis. Three 
hundred and sixty-nine patients yielded potential pathogens 
from sputum cultures. Three hundred and thirty-five cultures 
were true positives, and cultures from 34 patients were 
false positives for a false positivity rate of 9.2*. One 
hundred and nineteen patients yielded no pathogen. In 71 of 
these patients, criteria for pneumonia were not met. Forty-
eight of these patients had a bacterial infection of the 
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pulmonary parenchyma, but 44 of the 48 had received 
antimicrobial drugs before the procedure. The author 
concluded that transtracheal aspiration is a reliable 
technique for determining the cause of bacterial infections 
of the pulmonary parenchyma if there has been no prior 
treatment with antimicrobial drugs. 
Davidson (23) and colleagues studied 25 adult Navaho 
Indian patients with acute pneumonia and compared cultures 
of sputum, transtracheal aspirate and fluid obtained by 
direct-needle aspiration of the lung. Multiple potential 
pathogens were recovered from 83% of the sputum specimens, 
from 21% of the transtracheal aspirates, and from 16% of 
lung aspirates. Eighty percent of the positive lung 
aspirate cultures yielded a single bacterial isolate. The 
authors concluded that lung aspiration was more likely to 
yield single, definitive bacterial isolates than the other 
sampling techniques. 
Adult Respiratory Distress Syndrome (ARDS) is a 
respiratory condition due to acute lung injury with multiple 
causes. This syndrome is characterized by hypoxemia, 
increased lung stiffness and diffuse infiltration of the 
lung parenchyma as seen on radiographic examination of the 
chest. All of these abnormalities are related to an 
increase in the permeability of pulmonary capillary 
endothelium (42). Conditions frequently associated with 
ARDS include shock, septicemia, pulmonary infection, trauma, 
aspiration, inhaled toxins and metabolic disorders (67). The 
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presence of ARDS makes the diagnosis of pneumonia difficult 
and further confusion may arise due to the frequent 
colonization of the sputum of these patients with Gram-
negative bacilli (45). Andrew reviewed the postmortem 
histology of 24 patients with ARDS, and found that the 
accuracy of the clinical diagnosis of pneumonia in the ARDS 
patient was only 64% (4). 
Descriptive Epidemiology 
The reported incidence of pneumonia will vary from 
institution to institution, but data obtained from NNIS 
(14) in 1984 indicated that 6.0 cases of nosocomial 
pneumonia occurred per 1,000 patients discharged from U.S. 
hospitals. This represented 17.8% of all hospital associated 
infections. In addition, data from the 1986 NNIS study 
reported the incidence of HAPs by service. Among large 
teaching hospitals, the Surgical service accounted for 11.2 
cases of HAP per 1000 discharges, and the Medical service 
for 10.2 cases per 1000 discharges, the Pediatrics service 
for 3.9 cases per 1000 discharges, the Newborn service for 
2.9 cases per 1000 discharges, the Gynecology service for 
2.6 cases per 1000 discharges and the Obstetrics service for 
0.5 cases per 1000 discharges. In 1974, Pierce and Sanford 
(72) stated that nosocomial pneumonia has been estimated 
to occur in from 0.5 to 5% of all patients. Dixon stated 
that approximately 5 to 10 of every 1,000 hospitalized 
persons will develop an HAP, and he estimated that 238,000 
persons acquire these infections in the United States each 
year (25). 
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Certain hospital areas have appeared to experience an 
increased incidence of HAPs. Hemming (39) reported that 
7.2* of the patients in a newborn intensive care unit 
developed an HAP. Johanson and co-workers (46) observed an 
HAP rate of 12.2* in patients hospitalized in a general 
medical intensive care unit, and 17.5* of the postoperative 
patients in the study of Garibaldi et al developed an HAP 
(30). 
In a retrospective study by Stevens (96), 153 patients 
with pneumonia were identified during the first 2 1/2 years 
of operation of a respiratory-surgical ICU. Patients who 
had pneumonia due to GNB other than P^ aeruginosa had a 
mortality of 33*. On the other hand, isolation of 
E§§lJdgmonas from respiratory cultures obtained from patients 
with pneumonia was associated with a mortality of 70*. Data 
from the Comprehensive Hospital Infections Project (CHIP) 
(93) showed that HAP had a case-fatality ratio of 56* for 
bacteremic patients and 19* for nonbacteremic patients. The 
CHIP study was performed by the CDC in 1977 and was based on 
nosocomial infections reported from eight national hospitals 
over a two year period. Gross and colleagues (36) studied 
100 consecutive patients who died at Columbia-Presbyterian 
Medical Center and 100 consecutive patients who died at 
Hackensack Hospital to assess the importance of nosocomial 
infections as a contributory cause of death in patients who 
die in the hospital. By definition, these nosocomial 
infections were considered to be "contributing to death" 
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when the infection was an active infection of a major organ 
and "causally related to death" when the infection was not 
controlled at the time of death. Of 52 patients where 
hospital acquired infection (HAI) either contributed to or 
caused death, 31(60%) had HAP. In a study of 159 cases of 
HAP, Bartlett and associates (6) observed a mortality rate 
of 19* and in 13% of these patients, HAP contributed to 
death. 
HAPs have a significant financial impact. In 1977, 
Wenzel estimated this cost to be $208 per infection (101). 
Haley took this 1977 figure and adjusted it for inflation to 
predict the 1985 hospital costs. The average hospital 
charges for HAPs in 1985 were $4,947 per infection and the 
maximum costs were $41,628 (38). Dixon estimated the average 
per diem hospital cost.resulting from HAPs in 1984 to be 
$385 and the average prolongation of stay to be 4.0 days 
(26). 
Risk Factors 
Demographic factors. Stamm and associates observed in 
1977 that advanced age was a risk factor for the development 
of HAP (93). As a part of the Study on the Efficacy of 
Nosocomial Infection Control (SENIC), Hooten et al (40) 
developed an index of intrinsic patient risk. The SENIC 
study was carried out by CDC over a period of 10 years and 
included 338,000 general medical and surgical patients in 
338 hospitals (38). In the SENIC study, Haley et al (37) 
found that 13% of all nosocomial infections were HAPs. 
They observed that an increase in age from 18 to 85 years 
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was associated with a three-fold increase in the rate of 
HAP's, but did not indicate whether this was a statistically 
significant relationship. Unlike Stamm et al and Haley et 
al, Garibaldi and co-workers did not find a significant 
relationship between age and HAP. 
Stamm and associates (93) and the SENIC study (37) 
concur with respect to male sex being a risk factor for HAP. 
Stamm and associates found that males were approximately 3 
times more likely to develop HAP than females. The SENIC 
study found a greater male to female ratio (17.1:1) for the 
acquisition of HAP. On the other hand, Garibaldi and co­
workers (30) were unable to demonstrate a significant 
relationship between the male sex and HAP. 
Underlying disease. Hooten et al (41) found that 
diagnosis was an important determinant for infection when 
they constructed their risk index for HAP. 
Immunocompromised patients were at increased risk for HAP. 
Host defenses of these patients may be suppressed by 
underlying illness, or by treatment with corticosteroids, 
cytotoxic agents or other immunosuppressive drugs. Data from 
the SENIC study showed that persons on immunosuppressive 
therapy were 5.3 times more likely to develop HAP than 
persons not on such therapy. Sobel (91) stated that 
pneumonias account for as much as 25% to 50% of all 
infectious deaths among patients with hematologic 
malignancies. He also pointed out that the most important 
cause of death in acute leukemia is infection and that the 
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most common site is the lower respiratory tract. Similarly, 
Garibaldi and co-workers found a significant association 
between HAP and underlying non-malignant disease (p<0.005). 
A history of smoking (p<0.001) was also significantly 
associated with HAP, but no significant relationship was 
found between HAP and massive obesity (30). 
Duration of hospitalization. In the two studies that 
have assessed duration of hospitalization as a risk factor 
for HAP, both found a significant association between 
duration and infection. Stamm and associates (93) observed 
that hospitalization for more than 7 days significantly 
increased the risk for HAP. Although Haley and associates 
(37) also found duration a risk factor, they observed that 
the increased risk occurred only after 40 days of 
hospitalization (37). 
Presence of remote infection. Infection at various 
sites in the body may be a risk factor for hospital acquired 
infection. Two studies have shown that infection at a 
remote site is a risk factor for the development of 
postoperative wound infection (68,7). Only one study has 
assessed remote infection as a possible risk factor for HAP. 
Haley and associates (37) noted that previous infections at 
any site, regardless of whether these were community-
acquired or hospital-acquired, were associated with a 
fourfold increase in the risk of HAP. 
Surgery. Prior surgery was an important factor in the 
risk index developed by Hooten and associates (41). They 
observed that 74% of all pneumonia cases in adults occurred 
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in surgical patients (37). On the other hand, Garibaldi and 
co-workers found that 17.5* of 520 patients who underwent 
elective thoracic, upper abdominal and lower abdominal 
surgery developed HAP (31). Haley and associates found that 
patients who had combined thoraco-abdominal surgery had a 
risk 38 times that of other types of surgical procedures. 
When thoracic and abdominal operations were examined 
separately, there was a fourteen-fold greater risk for 
thoracic surgery and the risk was 3.4 times greater for 
abdominal operations than for other types of surgery (37). 
Garibaldi and co-workers (31) also observed that location 
of surgery was a risk factor for HAP. They found that 
pneumonia was highly associated with thoracic or upper-
abdominal surgery (p<0.001). Another risk factor related to 
surgery is duration of operation. The SENIC study found a 
49-fold increase in HAP in operative procedures of greater 
than 150 minutes (37). 
Ventilators. Patients exposed to ventilatory support 
have an especially high risk of acquiring HAP, although it 
is difficult to separate the contribution of respiratory 
care from that of intrinsic host susceptibility (25). The 
SENIC study found a 21-fold increase in risk for persons on 
ventilatory support compared to those not on ventilatory 
support (41). 
During the 1960s and early 1970s, respiratory care 
equipment was reported to be a major source of HAP 
(77,72,94,35,49). Due to changes in procedures for cleaning 
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and disinfection or sterilization of respiratory therapy 
equipment, there has been a major reduction in hospital 
acquired pneumonia. A review by Cross and Roup (22) in 
1981 stated that respiratory equipment is now rarely a 
direct cause of HAPs. 
Nevertheless, mechanical ventilation is still a risk 
factor for HAP. Cross and Roup prospectively studied 13,086 
patients hospitalized at Walter Reed Army Medical Center 
over an 11-month period and found that HAP developed in 7.7% 
of patients who received respiratory support compared to 
0.3% of patients who had no exposure to such therapy. No 
case of HAP occurred in patients on ventilators less than 24 
hours, but the risk of HAP increased significantly after the 
fifth day of respiratory therapy. The highest incidence of 
HAP occurred in patients with tracheostomy combined with 
ventilatory support (66.7%). The rate of infection for 
patients with tracheostomy who were not on a ventilator was 
25%. The rate of HAP was lower still for patients who had 
endotracheal intubation and ventilatory support, and was 
lowest for patients who were intubated but did not require 
ventilatory support (1.3%). 
Because of the potential for bacterial contamination of 
the system (i.e., the breathing circuit which connects to 
the endotracheal tube), the CDC recommends that the circuit 
be changed every 24 hours. There are no data to support 
this recommendation, and workers from the CDC acknowledge 
that the risk is probably low (90). In general, the CDC 
recommendations to change solutions or equipment are based 
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on control measures practiced during equipment-associated 
outbreaks. 
In 1984, Craven and colleagues (18) reported on 
ventilator circuit practices in the United States. Two 
hundred and forty-nine hospitals across the nation were 
surveyed. The majority (94.4*) changed their ventilator 
tubing every 24 hours, and 5.6% changed the circuits every 
48 hours. The scientific data available to guide hospitals 
in the routine change of ventilatory circuits is very 
limited. Most hospitals indicated that "self-study" was 
used to determine the time interval of ventilator circuit 
changes (19). Although the microbial study by Craven and 
co-workers indicated that there was no difference in 
contamination of circuits changed at 24 or 48 hours, only 
epidemiologic studies that provide rates of HAP can lead to 
definitive recommendations. In 1986, Craven and coworkers 
(21) published the results of their prospective, randomized, 
epidemiologic study of the effect of 24 versus 48 hour 
circuit changes on the rate of HAP. They found a 
significantly higher rate of HAP in patients whose 
ventilator circuits were changed every 24 hours. These 
authors suggested that ventilator circuits now may be 
changed safely every 48 hours. 
Outbreaks 
Under normal conditions the upper airway humidifies 
inspired air and prevents drying of mucus membranes of the 
bronchial tree. This maintains normal function of the 
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mucociliary apparatus, hydration of the bronchial tree, and 
prevents bronchial secretions from becoming thick and 
inspissated. 
Humidification by Nebulizers 
A nebulizer is one means of providing humidification of 
the gases from a respirator. Most commonly, these are fine 
particle reservoir nebulizers which operate on the venturi 
principle. A gas under pressure is directed across the 
mouth of a capillary tube in which the lower end of the tube 
is submerged in a reservoir of water. The negative pressure 
produced at the mouth of the capillary tube by the rapidly 
flowing gas, draws water from the reservoir into the gas 
stream. The water is impacted against a baffle, dispersed 
into droplets, and carried out of the nebulizer in 
particulate form (50). From there, it passes through the 
breathing circuit to the patient. Nebulizers create an 
aerosol that contains particles (1-2 u) that can be 
deposited into the lower respiratory tract (90). Units 
utilizing nebulizers have been shown to be hazardous, 
because the water droplets constitute an excellent vector 
for transmitting bacteria (77). 
Nebulizers may also generate an aerosol with 
ultrasound produced by rapidly vibrating crystals or by 
centrifugal force where liquid is dropped onto a rapidly 
spinning disk (100). Nebulizers produce droplets of 
different size. Small droplets are most useful for the 
treatment of respiratory therapy patients. Smaller droplets 
are distributed more uniformly in the lung tissue and 
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hydrate the patient more evenly and slowly. Therefore, 
larger droplets usually are removed from the treatment 
aerosol by a baffle (59). 
Hymidification by Humidifiers^ 
The alternative method for providing moisture for 
these gases is by a humidifier designed to deliver a water 
vapor to the patient as molecular water. The gas is heated, 
and the water vapor content is increased by either a bubble-
type humidifier or a wick humidifier. In the bubble-type 
humidifier, the gas bubbles through 250-300 cc. of heated 
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water (approximately 36 C). In the wick-type humidifier, 
gas is humidified by passing over a wick which is 
moisturized by a reservoir of water. The gas cools as it is 
transported to the patient, and cooling causes the water 
vapor to condense in the delivery tube (77). Because water 
droplets are not produced, humidifiers are considered a low 
risk as potential sources of infection. 
Microbiology of Nebulizers and Humidifiers 
Nebulizers The first microbiologic study of 
respiratory therapy equipment was reported in 1958 by 
Macpherson (57). He examined water from the 
reservoir, oxygen from the wall connection, several valves, 
and outlet ducts of nebulizers in use at Ohio State. He 
recovered large numbers of microorganisms only from water 
and outlet ducts. The majority (greater than 43X) were 
members of the family Enterobacteriaceae. The remainder 
were made up of a variety of organisms (yeast, Gram-positive 
37 
organisms and Pseudomonas). Alarmingly, Clostridium welchii 
also was isolated. Therefore, the author initiated several 
techniques designed to prevent contamination. These were 
probably the first infection control guidelines for 
inhalation therapy equipment. These guidelines were: 
1. Use only sterile water; 
2. Limit use to one week; 
3. Discard residual water prior to refilling; 
4. Clean and disinfect the reservoir prior to the next use; 
5. Replace defective washers prior to the next use; 
6. Autoclave the metal top of the humidifier between 
patients or after one week; 
7. Store all apparatus in the dry state; 
8. Use disposable tubing whenever possible; 
9. Take bacteriological samples at regular intervals. 
In 1965, Reinarz and coworkers cultured respiratory 
therapy equipment from six hospitals (77). Using an 
Andersen air sampler, 226 ventilators with and without 
nebulizers were sampled. Between 75-91* of all the tested 
equipment yielded significant numbers of GNB in the effluent 
air of the ventilators. There was a difference, however, 
between ventilators with and without mainstream nebulizers. 
Nearly all of the devices with mainstream nebulizers were 
contaminated. Forty-five percent generated aerosols with 
particles that ranged between 1.4 and 3.5 u. Further, there 
were 2,500 viable bacteria per 7.5 L of air. The prevalence 
and degree of contamination were similar in each hospital. 
Only 16* generated aerosols with viable particle counts as 
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low as those in ambient air (not exceeding 5 particles per 
7.5 L of air). Contaminated aerosols never were obtained 
from the 52 ventilators without mainstream reservoir nebuli­
zers, suggesting that the contamination was related to the 
reservoir nebulizer. Correlation between fluid samples from 
the nebulizers and the aerosol samples was performed. In 
81% of the samples there was correlation of all organisms or 
the predominant organisms. The major contaminants were 
E§§ydomonas spec i es x Flavobacteria species^ Here Ilea lAci-
netobacterl species^ and Achromobacter species^ 
Morris (65) evaluated bacterial contamination of 
aerosol generating equipment. Bacteria were recovered from 
46% of 382 water specimens that were collected from the 
nebulizers used on 15 patients. Twenty-four percent of the 
specimens were contaminated with GNB. E^aeruginosa 
accounted for 54% and Providencia stuartii for 21% of all 
GNB isolated. The remainder of the cultures yielded 
Staphylococcus species and Bacillus species. 
While most infections related to use of nebulizers have 
been due to contaminated mainstream nebulizers, 
contamination of medication nebulizers also may produce 
infectious aerosols resulting in ventilator-associated 
pneumonia. Two outbreaks of infection due to contamination 
of aerosol solutions in medication nebulizers have been 
reported (62,84). Medication nebulizers are infrequently 
associated with production of contaminated aerosols, because 
the small volume of these nebulizers permits drying between 
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use (72). Craven and coworkers (20) observed that 79% of 
cultures from in-use medication nebulizers were positive 
culturally for Gram-negative bacilli, frequently in heavy 
growth. In addition, it was shown that 71% of the 
nebulizers which were culturally positive produced bacterial 
aerosols. These observations were corroborated by in vitro 
studies in which bacteria were added to these nebulizers. 
The authors demonstrated that, under these conditions, the 
nebulizers also produced aerosols. Further, these aerosols 
were made up of particles with a diameter small enough to 
allow deposition in the alveoli. Thus, it would appear that 
although medication nebulizers usually provide a low risk to 
patients, they should be cleaned after each use. 
In their review of the literature, Simmons and Wong 
(90) pointed out that nebulizers can become contaminated by 
the introduction of nonsterile fluids, by manipulation of 
the nebulizer reservoir and perhaps by retrograde flow of 
condensate from the inspiratory limb of the breathing 
circuit. Bacteria in the reservoir can multiply to high 
concentrations within 24 hours, and place the patient at 
high risk for infection. 
Hysidifiers. Introduction of bubble-type humidifiers in 
1967 reduced the risk of bacterial contamination of gases 
during humidification. Schulze, Edmondson, Pierce and 
Sanford (88) examined 100 humidifiers for bacterial 
contamination after use. In 90% of the samples taken from 
the gas stream of ventilators using bubble-type humidifiers, 
the concentration of bacteria in the gas was comparable to 
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the concentration of bacteria in room air. Bacterial 
concentrations greater than 2,500 CFU per 7.5 L of gas were 
found in the effluent of only 2% of the machines. The 
authors compared these results to those of Reinarz and 
coworkers (77) who had demonstrated bacterial contamination 
at a concentration greater than 2,500 CFU per 7.5 L of gas 
in a high percentage of machines using mainstream reservoir 
nebulizers. They concluded that the machines with bubble-
type humidifiers are unlikely to produce respiratory 
infection. 
There is widespread belief that bubble-type humidifiers 
do not produce aerosols. Using an unheated bubble-type 
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humidifier with 10 to 10 microorganisms/ml of Pseudomonas, 
and water, Ahlgren recovered bacteria from the effluent air 
of the humidifier at a flow rate of 5 L/min (1). In 1986 
Rhame and associates (79) demonstrated that bubble-type 
humidifiers may aerosolize water. They added aeruginosa 
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(6.4 x 10 organisms per ml) to the water of various types 
of unheated humidifiers, and then sampled the air discharged 
from each humidifier. With a gas flow between 10 and 80 L 
per minute, bubble-type humidifiers produced between 460 and 
999 water droplets. With wick-type humidifiers, ho water 
particles were produced. Although the risk for infection to 
patients is unknown, the authors supported the 
recommendation that sterile water be used in bubble-type 
humidifiers. On the other hand, Goularte and coworkers (33) 
showed that even with a high inoculum, essentially no 
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bacteria were recovered from the effluent when the 
humidifier was heated and operated at a flow rate that is 
commonly used for patients on artificial ventilation. 
Description of Outbreaks 
Reinarz, Pierce et al (77,71) reviewed autopsy records 
at Parkland Memorial Hospital in Dallas to determine the 
incidence of necrotizing pneumonia in the years 1952, 1957 
and 1963. These years were chosen since they were prior to 
the widespread use of respiratory therapy equipment. The 
authors found that the rate of pneumonia caused by GNB had 
increased from 0.8% in 1952, to 1.8% in 1957, and to 9% in 
1963. They suggested that this increase was due to the use 
of reservoir nebulizers with contaminated water, since other 
predisposing factors, including broad spectrum antibiotics 
and steroids, had been introduced prior to the use of 
reservoir nebulizers. They then instituted guidelines for 
the care of nebulizers. In 1966-67 they supported this 
interpretation when they reported a decrease in the presence 
of pneumonia (from 9% to 2.2% and 2.1%, respectively) and 
the parallel decrease in the contamination of nebulizers 
from 84% to less than 10%. 
During the 1960s and 1970s many epidemics of Gram-
negative pneumonia were investigated, and various components 
of respiratory care equipment were found to be contaminated 
with the epidemic strains (70,62,80,65,77). In 1965, 
Phillips and Spencer (70) investigated eight patients who 
had been treated by tracheostomy and mechanical ventilation 
and had become infected. The authors cultured the 
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ventilators, the humidifier and breathing inspiratory 
tubing. All were heavily contaminated with the causative 
organism which was being delivered to the patients' 
tracheas. The routine cleaning method did not eliminate the 
organism. They then recommended disinfection by ethylene 
oxide. In addition, they proposed that a suitable bacterial 
filter be developed and placed in the respiratory circuit. 
Mertz et al (62) reported on an outbreak of pneumonia 
caused by EI?eu5!°!2i§§ • The outbreak occurred over a 
period of 22 days and involved 5 patients who had received 
contaminated bronchodilator solution and developed 
pneumonia. All 5 patients died. pneumoniae Type II was 
isolated from bottles of bronchodilator stock solution and 
the throat of a therapist who occasionally prepared these 
solutions. It was not indicated whether the therapist was 
the original source of the strain. To control the epidemic, 
the author suggested that all medications and solutions be 
prepared daily and that prolonged storage of premixed 
solutions no longer be permitted. 
Sanders and co-workers (84) reported on an outbreak due 
to Serratia marcescens which involved 374 patients during a 
ten-month period. The organism was isolated from sputum of 
229 patients, the urine in 127 patients, surgical wounds in 
47 patients, blood in 14 patients and other sites in 56 
patients. Medications were stored for prolonged periods 
because they had been purchased in large volume (100 to 500 
ml). Even under refrigeration, bacterial contaminants 
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multiplied to high concentrations. These authors found that 
12 of 17 medication nebulizers were contaminated with 
Si marcescens, the same microorganism as that recovered from 
the contaminated medication bottles. The outbreak was 
controlled, but not eliminated) when medications were 
purchased in small volumes (30-60 ml) and were discarded at 
the end of each eight hour shift. 
Ringrose and colleagues (81) described an outbreak in 
which nineteen patients became colonized or infected with 
l§rcescens over a two month period. In their investigation, 
they sampled the aerosol of two ultrasonic nebulizers. 
Cultures yielded a heavy growth of SA jnarcescens. When 
these machines were removed from use, the isolation of 
§§E£atia appeared to return to baseline rates. 
Cartwright and Hargrave (10) reported on an outbreak of 
infection by aeruginosa. The authors demonstrated that 
the heating elements in the humidifier on the ventilator 
were the source of contamination. Tap water had been used 
to fill the humidifier over a 26-month period and the 
organism had formed a scale on the surfaces of the heating 
element. 
During the ten-year period between 1971 and 1980, CDC 
investigated only one nosocomial epidemic in the United 
States attributed to contaminated respiratory therapy 
devices (69). During the outbreak, 16 persons on 
ventilatory support had sputum that was positive culturally 
for Acinetobacter calcoaceticus. Four patients were 
colonized with the organism, seven patients had 
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tracheobronchitis and five pneumonia. All organisms 
exhibited a common biotype and a characteristic antibiogram. 
The epidemic strain could not be cultured from the 
environment, but pooled hand cultures from Respiratory Care 
personnel were positive for the epidemic isolate. The 
investigators found that the hands of only one Respiratory 
Care therapist were colonized with calcoaceticus. The 
therapist calibrated and assembled ventilators prior to use. 
He had had a mild dermatitis of his hands for many months. 
This outbreak was not caused by contaminated nebulizers or 
medications, but by extrinsic contamination of respiratory 
therapy equipment from the hands of a Respiratory Care 
therapist. 
Redding and McWalter (76) reported on an outbreak of 
E§®M<|omonas fluorescens in an ICU. Seven patients on 
ventilators for four days or more became colonized or 
infected. Bacteriologic examination of the ventilators 
revealed that humidifiers were the only source for P.. 
fll}or§§c§D§ • The distilled water container (8 L in size) 
used to fill the humidifiers also yielded the organism and 
was thought to be the reservoir for the Pseudomonas. 
In a prospective study, Im et al (44) attempted to 
identify the source of P.. aeruginosa that caused infection 
in three patients on mechanical ventilation in an ICU. All 
patients developed pneumonia with the same strain as that 
recovered from the ventilator tubing. In each case, this 
organism was recovered from the ventilator tubing prior to 
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its recovery from the trachea. The authors implicated the 
ventilator as the source of the organism that caused 
pneumonia in these patients. They stated that ventilator 
tubing disinfection was ineffective due to trapping of air 
and inadequate drying, allowing the proliferation of 
microorganisms in the tubing. 
Epidemiology of Ventilator Breathing Circuits 
Little information is available on the effect of 
ventilator breathing circuit changes on contamination or 
HAP. In 1978 Lareau et al (53) found no differences in the 
risk of HAP in patients exposed to ventilator breathing 
circuits changed at 8, 16, or 24 hour intervals. There were 
two independent approaches used in her study. First, she 
performed a bacteriologic as well as epidemiologic study on 
130 patients. In use aerosol sampling of 513 ventilator 
treatment periods showed bacterial contamination in 1.8S> of 
8 hour cycles, in 2.5% of 16 hour cycles, and 5.4% of 24 
hour cycles. These differences in contamination were not 
significant. In a second retrospective study, she compared 
the incidence of pneumonia in patients on ventilators for 
two one-year periods when ventilator circuits were changed 
every 8 hours or 24 hours. In 1973 ventilator circuits were 
changed every 8 hours on 213 patients receiving a total of 
1,096 days of ventilatory therapy. In 1976, when ventilator 
circuits were changed every 24 hours, 271 patients were 
treated for a total of 2,098 days. The incidence of HAP was 
the same for the one year periods (0.015 cases of pneumonia 
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per ventilator day). The author concluded that changing 
ventilator circuits every 24 hours provided adequate 
protection from HAP. 
In 1982 Craven and co-workers (17) found no 
statistically significant difference in the rates of 
bacterial contamination of breathing circuits changed at 24 
hour intervals (Group I) versus 48 hour intervals (Group 
II). In a prospective bacteriological study, ninety-five 
patients on continuous ventilation were studied. Two 
hundred and forty aerosol samples of the inspiratory tubing 
were obtained. Twenty percent of the aerosol cultures from 
Group I versus 14* of aerosol samples from Group II yielded 
high-level contamination. The high rates of air 
contamination were attributed to an artifact of sampling; 
during the extended sampling period, culture plates were 
contaminated by droplets of condensate. Quantitative 
analysis of colonization of the tubing also was performed. 
Ninety-three cultures taken from twenty-three patients in 
Group I and eighty cultures taken from thirty-one patients 
in Group II showed no significant difference in colonization 
rates between circuits changed at 24 and 48 hours. 
Concentration of microorganisms in the broth used in the 
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broth washout culture technique ranged between 10 and 10 
organisms per ml. Colonization at this level occurred in 15 
patients from each group. The organisms isolated from the 
sputum were predominantly GNB (i.e.,Pseudomonasx 
Acinetobacter and Klebsiella). The author suggested that 
the contamination of the tubing originated from the 
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patient's respiratory flora. 
In 1984, Craven and co-workers (18) provided further 
support for the concept that respiratory breathing tubing is 
usually colonized by the bacteria present in the patients' 
secretions. They suggested that condensate may be 
contaminated and pose a risk for HAP. They cultured 58 
ventilator circuits by taking samples of the proximal end of 
the inspiratory breathing tubing (end closest to patient) 
at 2, 4, 6, 8, 12, and 24 hours. After 24 hours, greater 
than 1000 CFU were present in the end of the tubing nearest 
the patient whereas there was no contaminatjion in the distal 
tubing (end closest to machine). At 2 hours 33%, at 12 
hours 67*, and at 24 hours 80% of proximal tubing sampled 
was colonized. Condensate from the breathing tubing was 
collected from 20 patients. The median level of 
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colonization was 3.0 x 10 organisms/ml. Seventy-six 
percent of the organisms isolated were GNB. The survival of 
Gram-negative and Gram-positive bacteria (K^ pneumoniaex A^ 
calcoaceticusx aeruginosa and aureus) in sterile water 
was examined. No significant increase or decrease in 
bacterial concentrations was observed. The author concluded 
that retrograde contamination from patients is the primary 
mode of condensate colonization. 
In 1985, Malecka-Griggs (60) reported a microbiological 
study of neonates' ventilator circuits that were changed at 
24 and 48 hour intervals. The author evaluated the 
significance of changes in microbial concentrations during 
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the two intervals. Over a two year period, 379 fluid 
samples and 100 aerosol samples were obtained from the 
disposable circuits of 23 premature infants. Only three of 
23 infants had respiratory tract colonization with 
pathogenic bacteria. One case of colonization occurred in 
phase I of the study when circuits were changed every 24 
hours, and two cases occurred in phase II when circuits were 
changed every 48 hours. During the second phase, the author 
noted increased colonization by potential pathogens, and 
this led to a restoration of 24-hour circuit changes. Two 
infants were infected, one with K^_ pneumoniae and aureus 
and the other with Pj. aeruginosa. With 24 hour changes of 
circuits (phase I), a 2.5% contamination rate was observed. 
With 48 hour changes of circuits (phase II), the 
contamination rate increased to 19%. These data suggested 
to the author that frequent changing of the neonate circuits 
reduces colonization and cross-infection with P.. aeruginosa. 
In 1986, Craven and colleagues (20) reported from 
Boston City Hospital the risk factors for pneumonia and 
fatality in 233 intensive care unit patients receiving 
continuous mechanical ventilation over a 15 month period. 
Hospital acquired pneumonia was diagnosed in 49 (21%) of the 
233 patients. The authors reported on eight risk factors 
significantly associated with the development of pneumonia: 
intracranial pressure monitoring, craniotomy, head trauma, 
treatment with cimetidine, 24-hour changes of the ventilator 
circuit, hospitalization during the Winter-Fall season, 
steroid treatment and coma. However, when the data were 
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analysed by stepwise logistic regression analysis, only the 
presence of an intracranial pressure monitor, treatment with 
cimetidine, hospitalization during the Winter-Fall seasons, 
and mechanical ventilator circuit changes every 24-hours 
remained significant. Age, sex, race, type of intensive 
care unit, shock, admission with pneumonia and positive end 
expiratory pressure were not significantly associated with 
pneumonia. Pneumonia was less frequent in patients who 
received ampicillin (p<0.03) or gentamicin (p<0.03) and more 
frequent for patients who received vancomycin (p<0.04). 
Ninety-five (41%) of the patients died in the hospital. 
Seventy-eight (82%) were receiving mechanical ventilation or 
had received mechanical ventilation within 48-hours of 
death. Patients who died during hospitalization had a 
significantly higher mean age than the survivors (59+ 17 
years versus 52+ 18 years [p=0.03]). After multivariate 
analysis, the significant risk factors for fatality were: 
creatinine equal to or greater than 1.5 mg/dl, admission 
with pneumonia, not having received nebulized 
bronchodilators, a long duration of mechanical ventilation, 
having no abdominal surgery, being transferred from another 
hospital or hospital ward and having coma on admission. 
Objectives of Study 
1. To determine the bacterial contamination rate of the 
breathing circuit at 24 or 48 hours 
2. To determine the incidence of pneumonia that develops 
in patients on ventilatory support where the breathing 
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circuit is changed either every 24 or 48 hours 
3. To study the bacterial flora of the patient who is 
intubated (i.e.has a nasotracheal, orotracheal, or 
tracheostomy tube) 
MATERIALS AND METHODS 
The study was a prospective, randomized, double-blinded 
study and included all adult patients who were admitted to 
intensive care units and received mechanical ventilation 
during the period from January 1, 1984 until December 
31,1984. Patients with pneumonia on admission, burn 
patients and persons younger than 17 years of age were 
excluded. Patients who were previously on a ventilator at 
another hospital could be enrolled in the study, but were 
excluded if they had pneumonia. 
ratory Therapy Equipment 
Each patient received mechanical ventilation via a 
nasotracheal, (National Catheter, Glen Falls, New York; 
Portex, Wilmington, Massachusetts) endotracheal (National 
and Portex) or tracheostomy tube (Shiley, Irvine, 
California; National Catheter, Portex) connected to one of 
the following volume ventilators: 1) Bennett MA-1 (Puritan 
Bennett, Linthicum Heights, Maryland); 2) Bear (Bournes 
Medical Systems, Riverside, California); 3) Emerson (J.H. 
Emerson, Cambridge, Massachusetts); and 4)Engstrom 
(Engstrom- division Gambro Inc., Barrington, Illinois). A 
Bennett MA-1 respirator was used by the majority of 
patients. These ventilators were used with one of the 
following humidifiers: 1) Cascade bubbling humidifiers 
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(Puritan Bennett); 2) Conchatherm wick humidifiers 
(Respiratory Care Inc, Arlington Heights, Illinois) and 3) 
Bird wick humidifiers (Bird Corp., Palm Springs, 
California). Only sterile distilled water was used in the 
humidifiers. All ventilators utilized a non-sterile 
disposable circuit (Dart Industries, Ocala, Florida). Prior 
to the study, all tubing and the connectors had been changed 
every 24 hours. 
B®Sdomization 
The patients were randomized by the Respiratory Care 
personnel into two groups. Group I consisted of patients 
who had their entire ventilator circuit and humidifier 
changed every 24 hours. Group II consisted of patients who 
had their entire ventilator circuit and humidifier changed 
every 48 hours. Patients were enrolled in the study by 
Respiratory Care personnel when in their estimation a given 
patient met the criteria for enrollment. Before placing a 
patient on ventilation, the Respiratory Care personnel 
selected a sealed envelope containing an index card on which 
were either the numbers 24 or 48 (Group I or II). Envelopes 
had been prepared by a person not associated with the study 
using a computer generated table of random numbers. After 
randomization, the card containing the number was reinserted 
in the envelope and the patient's name, hospital number and 
the date, time and results of randomization were written on 
the outside of the envelope, and the envelope was stored for 
future reference. A form indicating that the patient was 
enrolled in the study was taped onto the ventilator. 
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B1inding 
The author was blinded with respect to final diagnosis 
(infection versus no infection). Two pulmonary physicians 
evaluated all patients for lower respiratory tract infec­
tion. These physicians were blinded with respect to the 
timing of ventilator circuit changes. The technician in the 
Hospital Epidemiology Laboratory who processed cultures from 
the ventilators, and technicians from the Hospital 
Laboratory who processed sputum for culture also were 
blinded with respect to the timing of ventilator circuit 
changes. 
Epidemiology 
At the time of randomization, Respiratory Care 
personnel or Nursing personnel obtained a baseline specimen 
of respiratory secretions using a sterile suction catheter 
inserted into the endotracheal or tracheostomy tube. The 
specimen was collected as soon as possible after enrollment. 
These specimens were cultured in the Hospital Laboratory. 
The author maintained a log book of all persons randomized. 
Each morning, she reviewed the chart of each patient 
enrolled during the preceding 19 hours. Patients who did 
not meet criteria for enrollment were removed from the study 
at that time. 
When patients were enrolled in the study, the following 
information on each patient was collected: name, hospital 
number and location, age, sex, race, date of admission, all 
patient diagnoses, type of intubation, smoking history, 
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underlying pulmonary diseases, and other underlying 
diseases, and the presence of a ventriculostomy. While the 
patient was on ventilatory support, additional data 
collected included inclusive dates of ventilation, treatment 
* 
with antibiotics , muscle relaxants and antacids, surgical 
+ 
operations (including type of operation, region of 
incision, and duration of surgery), and results of blood 
cultures and daily cultures of respiratory secretions. 
If present at the time of collection of the daily 
sputum specimen, the author would macroscopically evaluate 
the sputum for absence or presence of "purulence". 
Otherwise, the description of the patient's sputum in the 
chart was used. Clinical and laboratory data for each 
patient (including temperature, blood pressure, the presence 
of chills, serum albumin and chest X-ray interpretations) 
were recorded daily by the investigator. 
Collection of Microbiologic Samples 
Patients on ventilatory support were followed by the 
author and cultures were obtained for the duration of 
ventilation, up to a period of 30 days. At the 
discontinuation of ventilation, the patients were followed 
clinically, bacteriologically, and radiographically for 72 
hours. On completion of followup, the author would supply 
the pulmonary physicians with all of the data on the patient 
• Only antibiotics given intravenously for> 48 hours during 
the period from 48 hours before the start of ventilatory 
support to the end of ventilatory support were recorded. 
+ Surgical procedures were recorded from 1 week prior to 
ventilation to discontinuation from the study. 
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except the microbiological results from the ventilator and 
timing of ventilator changes. Using the definitions given 
below, the physicians reviewed the clinical data and the 
chest X-rays to determine whether or not the patients had 
developed an HAP or bacteremia. This information was 
transferred to a computer form. 
When the patient's ventilatory circuit and humidifier 
were changed, the patient was ventilated with a 
resuscitation bag. When the circuit was disconnected from 
the patient, bacteriological cultures of the inspiratory 
phase gas were taken using quantitative methods. The 
ventilator was adjusted to a standard tidal volume of 2 L 
per minute, a ventilatory rate of 25 breaths per minute, and 
to the maximum flow rate for each ventilator used (75-125 
L/min). A 2-stage Andersen air sampler (Andersen Sampler, 
Inc, Atlanta, Georgia), was used to size the bacterial 
particles into those small enough to reach the lower 
respiratory tract and larger particles that would be 
filtered out in the upper respiratory tract. A sterile cup 
was attached to the end of the inspiratory tubing that had 
been proximal to the patient, and was placed over the 
sampling head of the sampler. The tubing was held flush to 
the sampler intake for one minute. An agar plate containing 
trypticase soy agar with 5% sheep blood was present in each 
stage of the sampler. 
When the Respiratory Care personnel detached the 
circuit from the ventilator, the author cultured the distal 
and proximal segments of the inspiratory and expiratory 
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tubing. The ends of the tubing were cultured by inserting 
a swab to a depth of 3 cm using a spiral motion. As the 
swab was withdrawn, it was moved in the opposite direction. 
The swab was streaked over 1/2 of a blood agar plate at the 
bedside. The two limbs of the Y-connector were cultured 
using the same technique. The condensate from the 
inspiratory tubing was drained from the distal orifice into 
a sterile container. An equal volume of double strength 
Brain Heart Infusion (BHI) broth was then added. Fifty ml 
of BHI broth were aseptically poured into the inspiratory 
tubing at the proximal orifice. The tubing was rotated back 
and forth 10 times. The tubing was stretched as it was 
emptied so that all internal surfaces of the convoluted 
tubing came into contact with the broth. The broth then 
was collected in a sterile cup. Next, the author gently 
swirled the humidifier to mix the water and aspirated a 1-3 
ml sample with a sterile syringe. 
To determine the extent to which contamination from the 
act of sampling itself contributed to positive cultures, 49 
unused circuits were cultured in the laboratory using the 
above described techniques. Only 25 of 400 samples from 
surfaces and fluids (6.3%) were positive. Only Micrococcus 
sp., coagulase-negative staphylocci and alpha hemolytic 
streptococci were recovered. Most cultures were positive at 
less than ten colonies. Thirteen of 22 (59%) of air samples 
were culture positive. However, eleven of thirteen (84.6%) 
had only one or two colonies recovered. The other two 
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positive air cultures had 3 and 7 colonies recovered, 
respectively. The only microorganism recovered in air 
cultures was coagulase-negative staphylococci. No 
pathogenic species were isolated from any of these cultures. 
2efinitions 
Microorganisms were considered either pathogenic 
or non-pathogenic. Microorganisms defined as non-pathogens 
are shown in Table 1. All other microorganisms were 
considered pathogenic. Pneumonia was defined as the 
appearance of purulent sputum, and a new or progressive 
infiltrate on chest X-ray. When these signs were present 
without microbiologic data, the case was considered 
clinically confirmed. When these criteria were met and 
cultures of respiratory secretions yielded a potentially 
pathogenic organism, the case was considered 
microbiologically confirmed (31,97,11). Tracheobronchitis 
was defined when sputum was purulent but chest X-ray 
revealed a stable infiltrate or no infiltrate. 
Tracheobronchitis also was confirmed microbiologically or 
clinically. Ventilator-associated infection was defined as 
pneumonia or tracheobronchitis that developed at least 48-
hours after start of ventilation or within 72 hours after 
ventilation was discontinued. Septicemia was defined as two 
or more positive blood cultures with a pathogenic organism 
in conjunction with two or more of the following clinical 
o 
signs: fever equal to or greater than 100 F, chills, and 
hypotension. 
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Table 1. Non-pathogenic Microorganisms 
Microorganisms 
Bacillus sp. 
Candida albicans 
Candida trogicalis 
Diphtheroids 
Enteric streptococci 
Micrococcus sp. 
Neisseria sp. 
Coagulase-negative staphylococci 
Alpha hemolytic streptococci 
Non-hemolytic streptococci 
Yeast (not further identified) 
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Microbiology 
Cultures of respiratory secretions were processed in 
the Hospital Microbiology Laboratory and were planted on 
eosin methylene blue agar (EMB), blood agar (BA), and 
chocolate agar (CA). Cultures were semi-quantitated using 
the following definitions. When growth was present in all 
three streaks, growth was considered to be heavy. When 
growth appeared only in the primary and secondary streaks, 
it was considered moderate. Growth limited to the primary 
streak was considered light. All microorganisms were 
identified using standard techniques (2,29). 
All cultures from ventilators were processed in the 
Hospital Epidemiology Laboratory. The BA plates and broth 
o 
cultures were incubated at 37 C. The agar plates were 
examined for growth at 24 and 48 hours, and colonies were 
counted and recorded. Broth cultures were incubated for 48 
hours and subcultured to BA and EMB agar. Duplicate 
quantitative cultures of the water from the humidifiers were 
performed. Prior to culturing, the specimens were agitated 
for ten seconds. One tenth ml of the specimen was inoculated 
on the surface of a BA plate and spread with a glass rod. 
One ml aliquots of water were inoculated into 1.0 ml of 
double strength BHI broth. Broth was incubated for 48 hours 
and subcultured to BA and EMB agar. All microorganisms were 
identified by standard techniques (2,29). 
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Statistical Analysis 
Data were analyzed using the university computer (IBM 
3081 mainframe computer). The SAS Statistical package was 
used in summarizing and analyzing the data (83). Categorical 
data were analyzed using a two-tailed Fisher's exact test. 
A t-test for test of equality of means was used in the 
analysis of continuous variables. The statistical power for 
detection of true differences between rates was determined 
by a method described by Cohen (15). Multivariate analysis 
was performed using the procedure for stepwise logistic 
regression in the SAS statistical package (83). Variables 
included in the models for logistic regression analysis were 
those found to have a significant or borderline significant 
association with infection by univariate analysis. 
RESULTS 
Four hundred and sixty patients thought to be 
without respiratory tract infection were randomized to 
receive circuit changes at 24 hours (Group I) or 48 hours 
(Group II). Two hundred and forty-nine persons were 
eliminated from analysis. One hundred and seventy-one of 
these persons were eliminated because ventilatory support 
was discontinued before the first circuit change (61 persons 
in the 24-hour group and 110 persons in the 48-hour group). 
Fifty of the 249 persons were eliminated, because it was 
later determined that pneumonia was present at the time 
ventilatory support had been initiated (25 persons were in 
the 24-hour group and 25 persons were in the 48-hour group). 
Five patients were eliminated from analysis, because they 
were ventilated for more than thirty days. All of these 
were in the 24-hour group. Twenty-three persons in the 24-
hour group were eliminated from analysis, because the 
period of ventilation was less than 48 hours. Thus, only 
patients having ventilatory support that lasted for at least 
48 hours (Group I and Group II) were included in the 
analysis. 
Two hundred and eleven persons were evaluable. Of 
these, 116 persons were in Group I and 95 persons were in 
Group II. There were 17 persons who had two separate 
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courses of ventilatory support and one person with three 
courses of ventilatory support. Thus, there were 230 
courses of artificial ventilation. 
Isf§2ti2QS and Outcome of Infections 
Pneumonia. Thirty-five patients developed pneumonia 
after being on ventilatory support. Thirty-five of 211 
patients (16.6%) developed pneumonia and 35 of 230 
ventilatory courses (15.2*) were complicated by pneumonia. 
Patients who developed pneumonia were on ventilatory support 
for an average of 9.4 days prior to infection (range 2-29 
days). The mean age of patients with pneumonia was 50.2 
years. Twenty-three patients were male and 12 were female. 
There were 19 whites and 16 blacks. Pathogens isolated from 
the sputum of patients with pneumonia are shown in Table 2. 
No pathogen was isolated from the sputum of ten patients 
( 2 8 . 6 % ) .  S p u t u m  y i e l d e d  o n e  p a t h o g e n  i n  1 4  p a t i e n t s  ( 4 0 % ) ,  
two pathogens in nine patients (25.7%) and three pathogens 
in two patients (5.7%). 
Tracheobronchitis. One hundred and eighteen patients 
developed tracheobronchitis while on ventilatory support. 
One hundred and eighteen of 211 patients (56.0%) developed 
tracheobronchitis, and one hundred and eighteen of 230 
ventilatory courses (51.3%) were complicated by 
tracheobronchitis. Patients who developed tracheobronchitis 
were on ventilatory support for an average of 6.3 days prior 
to infection (range 1-29 days). The mean age of patients 
with tracheobronchitis was 52.2 years. Sixty-three were 
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Table 2. Pathogens Isolated from the Sputum 
of Patients with Pneumonia 
Causative Organism 
* 
Frequency * of 
Pneumonias+ 
No Pathogen Isolated 10 28.6 
P§§udomonas aeruginosa 6 17.1 
iDi§r°bacter cloacae 5 CO
 
Escherichia coli 5 14. 3 
Hemophilus influenza 4 11.4 
Proteus mirabilis 4 11.4 
Klebsiella pneumoniae 4 11.4 
Staphylococcus aureus 3 8.6 
Enterobacter aerogenes 2 5.7 
Klebsiella oxytoca 2 5.7 
Acinetobacter calcoaceticus 2 5.7 
Qitrobacter diversus 1 2.9 
Erovidencia §tuartii 1 2.9 
• The total number of isolates is greater than the 
total number of cases of pneumonia because some 
cases had more than one causative organism 
+ Numbers in this column add up to greater than 
100 because some patients had more than one isolate 
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Table 3. Pathogens Isolated from the Sputum 
of Patients with Tracheobronchitis 
Causative Organism 
• 
Frequency % of 
Tracheobronchitis+ 
No Pathogen Isolated 41 34.7 
Proteus mirabilis 23 19.5 
P§§J!<iomonas §§£ygiQ2§>§ 18 15.3 
Staphylococcus aureus 18 15,3 
Escherichia coli 13 11.0 
Hemophilus influenza 11 9.3 
lQ£§E2l>acter cloacae 11 9.3 
Klebsiella pneumoniae 8 6.8 
Serratia marcescens 7 5.9 
iQterobacter aerogenes 6 5.1 
Acinetobacter calcoaceticus 5 4.2 
Klebsiella oxytoca 4 3.4 
Qitrobacter freundi 3 2.5 
Streptococcus pneumoniae 3 2.5 
P§§ydgmonas maltophilia 1 0.6 
Serratia 1iguefaciens 1 0.6 
* The total number of isolates is greater than the total 
number of cases of tracheobronchitis because some cases 
had more than one causative organism. 
+ Numbers in this column add up to greater than 100 
because some patients had more than one isolate 
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male and 55 were female. There were 58 whites and 60 
blacks. Pathogens isolated from the sputum of patients with 
tracheobronchitis are shown in Table 3. No pathogen was 
isolated from the sputum of 41 patients (34.7%). Sputum 
yielded one pathogen in 52 patients (44.1%), two pathogens 
in 16 patients (13.6%) and three pathogens in 9 patients 
(7.6%). 
Bacteremia. There were eleven cases of bacteremia in 
211 patients (5.2%). Isolates from blood and sputum of 
these patients are shown in Table 4. In two patients with 
pneumonia and three patients with tracheobronchitis, the 
species recovered from blood also was recovered from sputum 
before or at the same time it was recovered from blood. 
Outcome of Infections^ Mortality. Ventilator associated 
pneumonia was associated significantly with a fatal outcome 
(p= 0.0076). On the other hand, tracheobronchitis was not 
associated significantly with mortality (p = 0.71). 
Egidemiology 
Twenty-four versus Forty^eight Hour Circuit Changes. 
The results of randomization are shown in Tables 5-8. 
Randomization of patients to either 24-hour or 48-hour 
circuit changes (Group I or Group II) resulted in only two 
significant differences between Group I and Group II. 
Patients in Group II were significantly more likely to have 
a diagnosis of chest injury (p=0.04), and were significantly 
more likely to have received antacids (p=0.03). Thus, 
randomization worked very well as the two groups differed 
significantly in only two of fifty-four characteristics 
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Table 4. Cases of Septicemia: Microorganisms 
from Blood and Sputum 
Microorganisms 
from Blood 
Respiratory Infection -> Microorganisms 
from Sputum 
Enteric streptococci Pneumonia Ci diversis 
F\ aeruginosa Pneumonia Pi aeruginosa 
aureus Pneumonia Si aureus 
§i pneumoniae Pneumonia Pi mirabilis 
Ki pneumoniae Tracheobronchitis E. 
Si 
col i 
aureus 
Pi aeruginosa Tracheobronchit is Pi aeruginosa 
Pi mirabilis Tracheobronchit is Si aureus 
Si aureus Tracheobronchit is Si aureus 
§i aureus Tracheobronchitis p. 
Ei 
mirabilis 
col i 
Si roarcescens Tracheobronchit is Si ®arcescens 
Si 5?arcescens Tracheobronchitis Ki pneumoniae 
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Table 5. Results of Randomization: Demographic Factors 
Factor Group I Group II P value 
AGE (mean) 51.49 51.35 0. 96* 
SEX (male/female) 70/46 48/47 0. 17 
RACE (white/black) 62/54 43/52 0. 27+ 
* t-test 
+ Fisher's exact test (2-tail) 
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Table 6. Results of Randomization: Admitting Diagnoses 
Characteristic Group I 
Absent-Present 
Group II P value 
Absent-Present 
Infectious Diseases 112 4 91 4 1. 00 
Diabetes mellitus 99 17 74 21 0. 21 
Hematologic Diseases 112 4 94 1 0. 38 
Neurologic Diseases 108 8 86 9 0. 61 
Coma 114 2 94 1 1. 00 
Seizures 110 6 91 4 1. 00 
Head Injury 97 19 78 17 0. 85 
Cardiac Diseases 70 46 47 48 0. 13 
Cerebrovascular 
Disease 
103 13 84 11 1. 00 
Peripheral Vascular 
Diseases 
102 14 85 10 0. 83 
Respiratory Diseases 96 20 68 27 0. 07 
Chest Injury 111 5 83 12 0. 04 
Gastrointestinal 
D iseases 
95 21 82 13 0. 45 
Skin and Subcutaneous 
Tissue Diseases 
115 1 95 0 1. 00 
Skeletal Diseases 112 4 93 2 0. 69 
Renal Diseases 100 16 74 21 0. 15 
Renal Transplant 116 0 93 2 0. 20 
Neoplastic Diseases 87 29 82 13 0. 06 
* Fisher's exact test (2-tail) 
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Table 6. Results of Randomization: 
Admitting diagnoses(cont'd.) 
Characterist ic Group 
Absent-
I 
Present 
Group 
Absent-
II 
Present 
• 
P value 
Neoplastic Diseases 87 29 82 13 
CO o
 
o
 
Psychiatric Diseases 113 3 92 3 1.00 
Ethanol Abuse 101 15 80 15 0.56 
Drug Abuse 115 1 95 0 1.00 
• Fisher's exact test (2-tail) 
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Table 7. Results of Randomization: Medications 
Medication Group I Group II P value 
Absent--Present Absent--Present 
Any Antibiotics 33 83 33 62 
* 
0.37 
Aminoglycosides 83 33 71 24 0. 64* 
* 
Cephalosporins 76 40 64 31 
(• 
*
 
00 00 o
 
Penicillins 74 42 63 32 0. 77 
Number of 
Antibiotics(mean) H-1
 
1—
» 
CO
 
1.09 0.52+ 
Antacids 72 44 44 51 0.03* 
* 
Cimetidine 78 38 67 28 0. 66 
* 
Pancuronium 96 20 75 20 0.49 
* Fisher's exact test (2-tail) 
Table 8. Results of Randomization: 
Epidemiologic Characteristics 
Characteristic Group I Group II P value 
Absent-Present Absent-Present 
Ventilated in Fall-
Winter 
Smoking History 
Current Smoker 
54 
36 
62 
60 
45 
33 
50 
41 
1.00* 
0.43* 
* 
Ever Smoked 
Type of intubation 
Nasotracheal 
23 
62 
73 
54 
27 
55 
47 
40 
T 
0.09 
0.58* 
Orotracheal 64 52 49 46 0.68 
± 
Tracheostomy 105 11 82 13 
T 
0.39 
ICU location 
General Medical 93 20 78 17 1. 00* 
Respiratory 108 5 88 7 
T 
0.39 
* 
Coronary 105 8 91 4 0.55 
± 
Neuroscience 76 37 65 30 0.88 
± 
General Surgery 70 43 58 37 1.00 
± 
Surgical Operations 40 76 39 56 0.39 
Types of Surgery 
Cranial 54 22 43 13 0.55* 
* 
Thoracic 54 22 43 13 
T 
0.55 
* 
Abdominal 46 30 26 30 0. 12 
Other 13 63 12 44 0.65* 
* 
Ventriculostomy 109 7 90 5 1.00 
Duration of Surgery 4: 42 4: : 55 
"T 
0. 66 
Ventilation Duration 5. 3 d. 7 d. 0.0532 
* Fisher's exact test 
+ t-test 
(2 -tail) 
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examined. 
There were fifteen cases of pneumonia in Group I (13*) 
and twenty cases of pneumonia in Group II (21.1%). The 
difference in infection rates between Group I and Group II 
was not significant (p=0.14). With these rates and the 
sample size of 211 patients on ventilatory support, the 
probability of detecting a significant difference is 47% 
(statistical power = 47%). Thus, it would be possible to 
detect a true difference in these rates only about half of 
the time. A sample size of 523 persons would have been 
required to reach 80% power. 
There were 68 cases of tracheobronchitis in Group I 
(58.6%) and 50 cases of tracheobronchitis in Group II 
(52.6%). The difference between the tracheobronchitis rates 
was not significant (p = 1.00). With these rates and the 
sample size of 211 patients on ventilatory support, the 
probability of detecting a significant difference is 21.8% 
(statistical power = 21.8%). Thus, it would be possible to 
detect a true difference in these rates only about one fifth 
of the time. A sample size of 1,704 persons would have been 
required to reach 80% power. 
Bisk Factors for Infection. Three sets of analysis for 
identification of risk factors were performed. First, 
patients with pneumonia were compared to patients without 
pneumonia. In the second analysis, patients with pneumonia 
were compared to patients who had no infection (patients 
with tracheobronchitis were excluded from the group of 
patients without pneumonia). In the third analysis, 
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patients with tracheobronchitis were compared to patients 
who had no infections. 
Results of the first analysis are shown in Tables 9-12. 
Risk factors for pneumonia included head injury, chest 
injury, other types of surgery (surgery that was not 
cranial, thoracic or abdominal), having been hospitalized in 
the neurosciences ICU and a longer duration of ventilation. 
Two factors were identified that appeared to protect 
patients from developing pneumonia. These included having 
received any antibiotics, and having a nasotracheal tube 
rather than an orotracheal tube or tracheostomy. 
Results of the second analysis are shown in Table 13-
16. For this analysis, patients with tracheobronchitis were 
removed from the group of patients without pneumonia. Thus, 
in this analysis, patients with pneumonia were compared with 
patients without any respiratory tract infection. When the 
analysis was performed in this manner, chest injury and 
other types of surgery were no longer risk factors for 
pneumonia. However, three additional risk factors were 
identified including use of pancuronium, ventilation by way 
of a tracheostomy and presence of a ventriculostomy. This 
analysis appeared to sharpen the differences between 
pneumonia and patients who did not develop pneumonia while 
on ventilatory support. As in the first analysis, duration 
of ventilation was significantly associated with development 
of pneumonia. Use of antibiotics and nasotracheal 
intubation were again found to be protective. 
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Table 9. Patients with Pneumonia versus Patients 
++ 
without Pneumonia: Demographic Factors 
Factor Pneumonia No Pneumonia P value 
AGE (mean) 50.20 51.67 0.68* 
+ 
SEX (male/female) 23/12 95/81 0.26 
RACE (white/black) 19/16 86/90 0.58+ 
* t-test 
+ Fisher's exact test (2-tail) 
++ Patients with tracheobronchitis are included in the 
group of patients without pneumonia 
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Table 10. Patients with Pneumonia versus 
Patients without Pneumonia 
+ 
Admitting Diagnoses 
Characterist ic Pneumonia 
Absent-Present 
• 
No Pneumonia P value 
Absent-Present 
Infectious Diseases 35 0 168 8 0. 36 
Diabetes mellitus 33 2 140 36 0. 051 
Hematologic Diseases 33 2 173 3 0. 19 
Neurologic Diseases 33 2 161 15 0. 74 
Coma 35 0 173 3 1. 00 
Seizures 33 2 168 8 0. 67 
Head Injury 22 13 153 23 0. 002 
Cardiac Diseases 23 12 94 82 0. 20 
Cerebrovascular 
Diseases 
32 3 155 21 0. 77 
Peripheral Vascular 
Diseases 
32 3 155 21 0. 77 
Respiratory Diseases 29 6 135 41 0. 51 
Chest Injury 28 7 166 10 0. 01 
Gastrointestinal 
Diseases 
29 6 148 28 0. 81 
Skin and 
Subcutaneous Diseases 
35 
i
0 175 1 1. 00 
Skeletal Diseases 34 1 171 5 1. 00 
+ Patients with tracheobronchitis are included in the 
group of patients without pneumonia 
* Fisher's exact test 
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Table 10. Patients with Pneumonia versus Patients without 
Pneumonia: Admitting Diagnosis (cont'd.) 
Characteristic Pneumonia 
Absent-Present 
No Pneumonia 
Absent-Present 
P value 
Renal Diseases 33 2 141 35 0.05! 
Renal Transplant 35 0 174 2 1.00 
Neoplastic Diseases 32 3 137 39 0.10 
Psychiatric 
Diseases 
34 1 171 5 1.00 
Gthanol Abuse 30 5 151 25 1.00 
Drug Abuse 35 0 175 1 1.00 
* Fisher's exact test (2-tail) 
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Table 11. Patients with Pneumonia versus 
Patients without Pneumonia: 
• 
Medications 
Medication Pneumonia 
Absent-Present 
No Pneumonia P value 
Absent-Present 
+ 
Any Antibiotics 17 18 49 127 0.03 
Aminoglycosides 29 6 125 51 0.21 + 
+ 
0.85 
_1_ 
Cephalosporins 24 11 116 60 
Penicillins 26 
Number of antibiotics 
(mean) 
Antacid 9 
9 
0. 83 
16 
111 
97 
65 
1.21 
79 
T  
0.25 
++ 
0.5 
1.00+ 
i  
Cimetidine 23 12 122 54 
+ 
0.69 
Pancuronium 25 10 146 30 
T  
0. 15 
• Patients with 
group of patients 
tracheobronchitis are 
without pneumonia 
included in the 
+ Fisher's exact test (2-tail) 
++ t-test 
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Table 12. Patients with Pneumonia versus Patients 
• 
without Pneumonia: Epidemiologic Characteristics 
Characteristics Pneumonia No Pneumonia P value 
Absent-Present Absent-Present 
Ventilated in Fall- 8 2  9 4  1 7  1 8  0 . 8 5  +  
Winter 
Smoking History 
Current Smoker 1 1  1 5  5 8  8 6  0 .  8 3 +  
x  
Ever Smoked 8  1 8  4 2  1 0 2  1 . 0 0  
Type of intubation 
Nasotracheal 2 5  1 0  9 2  8 4  0 .  0 4 +  
x  
Orotracheal 1 7  1 8  9 6  8 0  0 . 5 8  
x  
Tracheostomy 2 8  7  1 5 9  1 7  
*t* 
0 . 0 9  
ICU location 
General Medical 3 2  2  1 3 9  3 5  0 . 0 5 1 +  
x  
Respiratory 3 1  3  1 6 5  9  
T  
0 . 4 2  
Coronary 3 2  2  1 6 4  1 0  1 . 0 0  
x  
Neuroscience 1 7  1 7  1 2 4  5 0  0 . 0 2 6  
x  
General Surgery 2 4  1 0  1 0 4  7 0  0 . 2 5  
x  
Surgical Operations 1 0 9  2 3  6 7  1 2  0 . 7 1  
Type of Surgery 
Cranial 1 6  7  8 1  2 8  0 . 6 1 +  
x  
Thoracic 1 8  5  7 9  3 0  
f  
0 . 8 0  
x  
Abdominal 1 6  7  5 6  5 3  
T  
0 .  1 7  
i  
Other 1 5  8  9 2  1 7  
T  
0 .  0 4  
i  
Ventriculostomy 3 1  4 1 6 8  8  0 . 1 2  
** 
Duration of Surgery 4 :  3 5  4 :  5 0  0 . 7 7  
** 
Ventilation Duration 9 .4 d. 5 . 4  d. 0 . 0 0 3 8  
• Patients with tracheobronchitis are included in i the 
group of patients without pneumonia 
+ Fisher's exact test ( 2 --tail) 
** t-test 
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Table 13. Patients with Pneumonia versus Patients 
without Infection: Demographic Factors 
Factor Pneumonia No Pneumonia P value 
AGE (mean) 
SEX (male/female) 
RACE (white/black) 
50.20 
23/12 
19/16 
49.89 
32/26 
28/30 
0.94* 
+ 
0.39 
+ 
0.67 
* t-test 
+ Fisher's exact test (2-tail) 
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Table 14. Patients with Pneumonia versus Patients 
without Infection: Admitting Diagnosis 
Characterist ic Pneumonia 
Absent-Present 
* 
No Pneumonia P value 
Absent-Present 
Infectious Diseases 35 0 55 3 0.28 
Diabetes mellitus 33 2 47 11 0.12 
Hematologic Diseases 33 2 57 1 0.55 
Neurologic Diseases 33 2 52 6 0.71 
Coma 35 0 57 1 1.00 
Seizures 33 2 55 3 1.00 
Head Injury 22 13 50 8 0.012 
Cardiac Diseases 23 12 36 22 0. 83 
Cerebrovascular 
Diseases 
32 3 55 3 0.67 
Peripheral Vascular 
Diseases 
32 3 53 5 1.00 
Respiratory Diseases 29 6 46 12 0.79 
Chest Injury 28 7 53 5 0. 13 
Gastrointestinal 
Diseases 
29 6 47 11 1.00 
Skeletal Diseases 34 1 57 1 1.00 
Renal Diseases 33 2 46 12 0.07 
Neoplasms 32 3 43 15 0.06 
Psychiatric Diseases 34 1 55 3 1.00 
Ethanol Abuse 30 5 49 9 1.00 
• Fisher's exact test (2-tail) 
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Table 15. Patients with Pneumonia versus 
Patients without Infection: Medications 
Medication Pneumonia No Pneumonia P value 
Absent-Present Absent-Present 
• 
Any Antiobiotics 17 18 15 43 0.042 
* 
Aminoglycosides 29 6 45 13 
T 
0.61 
* 
Cephalosporins 24 11 34 24 0. 38 
* 
Penicillins 26 9 39 19 0.64 
i 
Number of Antibiotics 0.83 1. 14 
T 
0. 15 
(mean) 
* 
Antacid 19 16 36 22 0.52 
* 
Cimet idine 23 12 44 14 
* 
0.34 
Pancuronium 25 10 53 5 
* 
0.018 
• Fisher's exact test (2-tail) 
+ t-test 
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Table 16. Patients with Pneumonia versus Patients 
without Infection: Epidemiologic Characteristics 
Characteristic Pneumonia No Pneumonia P value 
Absent-Present Absent-Present 
Ventilated in Fall-
Winter 
Smoking History 
17 18 28 30 1 . 0 0 *  
Current Smoker 11 15 18 29 0.81* 
* 
Ever Smoked 8 18 13 34 0.79 
Type of intubation 
Nasotracheal 25 10 25 33 0.01* 
* 
Orotracheal 17 18 35 23 
•
0.29 
* 
Tracheostomy 28 7 55 3 0.038 
ICU location 
General Medical 32 2 46 12 0. 07* 
Respiratory 31 3 55 3 
T 
0.67 
* 
Coronary 32 2 55 3 
•
1.00 
Neurosciences 17 17 43 15 0.02 
* 
General Surgery 24 10 33 25 
•
0. 27 
Surgical Operations 42 23 16 12 
• 
0.50 
Type of Surgery 
Cranial 16 7 37 5 0. 10* 
* 
Thoracic 18 5 27 15 0.28 
Abdominal 16 7 21 21 0. 19* 
Other 15 8 36 6 0.07* 
* 
Ventriculostomy 31 4 58 0 
T 
0. 018 
i 
Duration of Surgery 4: 35 4: 17 
"T* 
0. 62 
Ventilation Duration 9. 4 d. 3. 5 d. 0.0001 
* Fisher's exact test (2-tail) 
+ t-test 
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Table 17.Patients with Tracheobronchitis versus 
Patients without Infection: Demographic Factors 
Factor Infected Noninfected P value 
AGE (mean) 
SEX(male/female) 
RACE (white/black) 
52.53 
63/55 
58/60 
49.89 
32/26 
28/30 
*
 
+
 
+
 
00 
c
-
 
o
 
CO 
00 
o
 
O
 
O
 
r
H 
• t-test 
+ Fisher's exact test (2-tail) 
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Table 18. Patients with Tracheobronchitis versus 
Patients without Infection:Admitting Diagnosis 
* 
Characteristic Infection No Infection P value 
Absent-Present Absent-Present 
Infectious Diseases 113 5 55 3 0.72 
Diabetes mellitus 93 25 47 11 0.84 
Hematologic Diseases 116 2 57 1 1.00 
Neurologic Diseases 109 9 52 6 0.57 
Coma 116 2 57 1 1.00 
Seizures 113 5 55 3 0.72 
Head Injury 103 15 50 8 0.82 
Cardiac Diseases 58 60 36 22 0.11 
Cerebrovascular 100 18 55 3 0.08 
Disease 
Peripheral Vascular 102 16 53 5 0.46 
Disease 
Respiratory Disease 89 29 46 12 0.70 
Chest Injury 113 5 53 5 0.30 
Gastrointestinal 101 17 47 11 0.51 
Disease 
Skin and 117 1 58 0 1.00 
Subcutaneous Disease 
Skeletal Disease 114 4 57 1 1.00 
Renal Diseases 95 23 46 12 0.84 
Renal Transplant 116 2 58 0 1.00 
Neoplastic Disease 94 24 43 15 0.44 
Psychiatric Disease 116 2 55 3 0.33 
Gthanol Abuse 102 16 49 9 0.82 
Drug Abuse 117 1 58 0 1.00 
* Fisher's exact test (2-tailJ 
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Table 19. Patients with Tracheobronchitis versus 
Patient without Infection: Medications 
Medication Tracheobronchitis 
Absent-Present 
Non Infected 
Absent-Present 
P value 
Any Antibiotics 34 84 15 43 0. 
* 
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Aminoglycosides 80 38 45 13 0. 22* 
Cephalosporins 82 36 34 24 0. 18* 
Penicillins 72 46 39 19 0. 51* 
Number of 
antibiotics(mean) 
1.25 1. 14 0. 53 
Antacids 46 72 30 28 0. 20* 
Cimetidine 78 40 44 14 0. 
T 
22 
* 
Pancuronium 93 25 53 5 0.053 
• Fisher's exact test (2-tail) 
+ t-test 
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Table 20. Patients with Tracheobronchitis versus 
Patients without Infection: Epidemiologic Characteristics 
Characteristic Tracheobronchitis 
Absent-Present 
Non Infected P value 
Absent-Present 
Ventilated in Fall-
Winter 
Smoking History 
Current Smoker 
54 
40 
64 
57 t-*
 
00
 
Oi
l 
N
) 
£»
| 
CO
 
00
1 
1.00*" 
0. 86* 
Ever Smoked 29 68 13 34 0.85* 
Type of intubation 
Nasotracheal 67 51 25 33 0.11* 
* 
Orotracheal 61 57 35 23 0.33 
* 
Tracheostomy 104 14 55 3 
T  
0. 19 
ICU location 
General Medical 93 23 46 12 1.00* 
Respiratory 110 6 55 3 
T  
1.00 
Coronary 109 7 55 3 
• 
1.00 
± 
Neurosciences 81 35 43 15 
•
0.60 
* 
General Surgery 33 25 71 45 0.62 
Surgical Operations 42 67 16 51 
• 
0.049 
Types of Surgery 
Cranial 44 23 37 5 0.01* 
* 
Thoracic 52 15 27 15 0.19 
* 
Abdominal 35 32 21 21 
•
0.85 
Other 36 6 56 11 1.00* 
* 
Ventriculostomy 110 8 58 0 0.054 
Duration of Surgery 5: 11 4: 17 
T  
0 .  10 
Ventilation Duration 6. 3 d. 3. 5 d. 0 .0001 
• Fisher's exact test (2-
+ t-test 
tail) 
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Results of the third analysis are shown in Tables 17-
20. Only three risk factors were identified for 
tracheobronchitis. They were surgical operations in 
general, cranial operations and duration of ventilation. 
There were no factors that appeared to protect against 
development of tracheobronchitis. 
Multivariate analysis. Because many of the risk 
factors identified by univariate analysis may have been 
interrelated, these risk factors were subjected to 
multivariate analysis using a stepwise logistic regression 
procedure. All variables with a significant association or 
a borderline significant association with the occurrence of 
infection were included in the models. 
In the first analysis, where patients with pneumonia 
were compared with patients without pneumonia, variables 
included in the model for the logistic regression procedure 
included head injury, chest injury, other surgery, duration 
of ventilation, not having received antibiotics, not having 
a nasotracheal tube, location in the general medical ICU, 
and location in the neurosciences ICU. After logistic 
regression analysis, three variables remained associated 
significantly with pneumonia. These included duration of 
ventilation (p < 0.00009), not having received an antibiotic 
(p = 0.0013), and having sustained a chest injury (p = 
0.0019). 
In the second analysis, where patients with pneumonia 
were compared with patients without infection, variables 
included in the model for the logistic regression procedure 
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included head injury, treatment with pancuronium, having had 
a tracheostomy, duration of ventilation, location in the 
neurosciences ICU, not having received antibiotics, and not 
having a nasotracheal tube. After logistic regression 
analysis, three variables remained associated significantly 
with pneumonia. These included duration of ventilation (p = 
0.0001), not having received an antibiotic ( p = 0.002), and 
having received pancuronium (p = 0.0463). 
For multivariate analysis of the factors associated 
with tracheobronchitis, variables included in the model for 
stepwise logistic regression were having had any surgical 
operation, having had cranial surgery, having received 
pancuronium and duration of ventilation. When these 
variables were analysed by this procedure, only duration of 
ventilation remained significantly associated with the 
occurrence of tracheobronchitis. 
Microbiology 
Ten thousand and ten cultures were obtained from 1,247 
breathing circuits and 56.5% were positive. Ten and seven-
tenths percent of all cultures taken yielded a pathogen. 
Ninety and four-tenths percent of all cultures taken from 
the internal surfaces of the ventilator circuits were 
positive, and 6.6% of internal surface cultures of the 
ventilator circuits were positive for a pathogenic species. 
For condensate and humidifier water, the culture positivity 
rate was lower (74.7% and 3.2%, respectively). Pathogens 
were recovered from 38.2% of condensate cultures and 1.6% of 
the cultures of humidifier water. Forty-eight and two-
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tenths percent of stage 1 air cultures were positive. Only 
about one-half as many stage 2 air cultures were positive 
(26.3%). Pathogens were recovered from 9.5% of stage 1 air 
cultures and 4.7% of stage 2 air cultures. The rates of 
positive cultures for Group I and Group II circuits are 
shown in Table 21. 
Microorganisms Isolated from Circuits. The 
microorganisms isolated from circuits changed at 24 hours or 
48 hours are shown in Tables 22 and 23. Any microorganisms 
were isolated from 94.1% of Group I circuits and 93.7% of 
Group II circuits, and pathogens were isolated from 61.3% of 
Group I circuits and 66.2% of Group II circuits. The great 
preponderance of pathogens isolated from both 24 and 48 hour 
circuits were Gram-negative bacilli. S^. aureus was the 
major Gram-positive pathogen isolated from Group I and Group 
II circuits and outnumbered all other Gram-positive 
pathogens from 7:1 to 10:1. 
Cultures of Air. Microorganisms isolated from the air 
of the inspiratory limb of the circuit are shown in Tables 
24 and 25. Microorganisms were recovered from air of 54% of 
Group I circuits and 51.6% of Group II circuits. Twenty-
four percent of Group I positive air cultures yielded a 
pathogenic organism. Thirty-seven percent of the positive 
air cultures from Group II had one or more pathogens 
isolated. Fifteen to 20% of the agar plates in stage 1 were 
contaminated by condensate that dripped out of the proximal 
inspiratory limb during air sampling. Of all the pathogenic 
microorganisms present in respiratory circuits, only a 
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Table 21. Rates of Positive Cultures for Circuits 
Changed at 24 Hours versus 48 Hours 
Type of Culture Group I 
Number Rate(*) 
Group 
Number 
II 
Rate(%) 
Internal surfaces 
of circuits 496 88.6 304 92.1 
Condensate 397 73.7 236 75.6 
Water 16 3.0 10 3.3 
Air 276 54.0 146 51.6 
stage 1 256 50.4 129 45.9 
stage 2 142 28.0 68 24.5 
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Table 22. Microorganisms Isolated from 
• 
Circuits Changed every 24 Hours 
Microorganism Frequency % of Total Isolates 
Gram-positive cocci: 
Staphylococcus aureus 90 3.1 
Streptococcus pneumoniae 7 0.2 
Streptococcus pyogenes 2 0.1 
Gram-negative bacilli: 
P§§ydomonas aeruginosa 478 16.3 
Klebsiella pneumoniae 303 10.4 
Escherichia coli 257 8.8 
Proteus mirabilis 232 7.9 
Serratia marcescens 213 7.3 
Acinetobacter calcoaceticus 142 4.9 
Iot§E2t>§cter aerogenes 80 2.7 
Enterobacter cloacae 75 2.6 
Qitrobacter freundii 41 1.4 
Pseudomonas maltophilia 10 0.3 
Pseudomonas species 7 0.2 
Klebsiella oxytoca 6 0.2 
Hemophilus influenzae 6 0. 1 
Serratia 1iguefaciens 2 0.1 
Qitrobacter diversus 1 0.03 
Non-pathogens 973 33.3 
Total 2925 100 
* Includes cultures of all internal surfaces of the 
ventilator circuit, condensate, and water from the 
humidifier 
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Table 23. Microorganisms Isolated from Circuits 
• 
Changed every 48 Hours 
Microorganism Frequency % of Total Isolates 
Gram-positive cocci: 
Staphylococcus aureus 81 4.3 
Streptococcus pyogenes 4 0.2 
Streptococcus pneumoniae 3 0.2 
Gram-negative bacilli: 
Pseudomonas aeruginosa 477 25.4 
Acinetobacter calcoaceticusl43 7.6 
Klebsiella pneumoniae 130 6.9 
Proteus mirabilis 122 6.5 
Enterobacter aerogenes 90 4.8 
Enterobacter cloacae 86 4.6 
Serratia marcescens 86 4.6 
Escherichia col i 72 3.8 
Enterobacter agglomerans 10 0.5 
Citrobacter freundii 5 0.3 
Serratia liguefaciens 5 0.3 
Klebsiella oxytoca 4 0.2 
E§§udomonas maltophilia 4 
CM 
•
 
o
 
Pseudomonas species 4 0.2 
Hemophilus parainfluenza 2 0.1 
Hemophilus influenza 1 0.1 
Non-pathogens 547 29.2 
Total 1876 100 
• Includes cultures of all internal surfaces of the 
ventilator circuit,condensate,and water from the humidifier. 
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Table 24. Microorganisms Isolated from Air of Ventilator 
• 
Circuits Changed every 24 Hours 
Microorganism Frequency % of Total 
Cultures 
E§§udomonas aeruginosa 28 9.6 
Staghxlococcus aureus 8 2.7 
Acinetobacter calcoaceticus 7 2.4 
Serratia marcescens 6 2.1 
Escherichia col i 5 1.7 
Klebsiella pneumoniae 5 1.7 
Proteus mirabilis 5 1.7 
Enterobacter cloacae 2 0.7 
Enterobacter aerogenes 2 0.7 
Citrobacter freundii 2 0.7 
Non-pathogens 222 76.0 
Total 292 100 
* Isolates from stage 1 
sampler combined 
and stage 2 of the Andersen air 
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Table 25. Microorganisms Isolated from Air of Ventilator 
• 
Circuits Changed every 48 Hours 
Microorganism Frequency % of Total 
Cultures 
E§§ydomonas aeruginosa 32 19.8 
Serratia marcescens 5 3.1 
Staphylococcus aureus 5 3.1 
Enterobacter aerogenes 4 2.5 
Klebsiella gneumoniae 4 2.5 
Acinetobacter calcoaceticus 3 1.9 
Enterobacter cloacae 3 1.9 
Proteus mirabilis 2 1.2 
Enterobacter agglomerans 1 0.5 
Escherichia coli 1 0.5 
Non-pathogens 102 63.0 
Total 162 100 
* Isolates from stage 1 and stage 2 of the Andersen air 
sampler combined 
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limited number could be recovered from the air. The only 
pathogens isolated from Group I and Group II air cultures 
were S^aureus and the nine GNB most commonly isolated from 
circuit cultures (Tables 22 and 23). With one exception, 
the pathogenic species isolated from the air of Group I 
circuits were the same as those isolated from Group II 
circuits. Only two-thirds (8 of 12) of the pathogenic 
species isolated from the sputum of patients with pneumonia 
(Table 2) also were isolated from the air of respiratory 
circuits. However, P^. aeruginosa which was the pathogen 
most frequently isolated from the sputum of patients with 
pneumonia, was also the pathogen most frequently isolated 
from the air cultures. 
Cultures from Subgroups of Patients Randomized to 
Receive Circuit Changes at 24 Hours. In a subset of 23 
patients (Group IA), randomized to receive circuit changes 
at 24 hours, ventilatory support was discontinued after only 
one circuit change. In a subset of 116 patients (Group IB), 
randomized to received circuit changes at 24 hours, 
ventilatory support was continued for 48 or more hours. 
Since all circuits in Group IA were exposed only during the 
first 24 hours of ventilation, it was decided that Groups IA 
and IB should be analyzed separately. Results of the 
analyses where Group IA is compared with Group IB are shown 
in Tables 26 and 27. As can be seen in Table 26, circuits 
in Group IB are significantly more likely to be culture 
positive than cultures in Group IA when circuit cultures 
(all components) and internal surfaces of circuits are 
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Table 26. Culture Results from Circuits in Group IA 
* 
and Group IB: Positive Cultures versus Negative Cultures 
Source of Group IA Group IB 
Culture Microbial Growth Microbial Growth P value+ 
Absent/Present Absent/Present 
Circuit cultures 5 21 33 527 0.02 
(all components) 
Circuit cultures 8 18 64 496 0.008 
(internal surfaces) 
Condensate 8 13 142 397 0.31 
Humidifier Water 20 1 511 16 0.49 
Air cultures 9 9 235 276 0.81 
(Andersen air sampler) 
1st stage only 12 6 252 256 0.23 
2nd stage only 12 5 364 142 1.00 
• Group IA was made up of patients who were on the 
ventilator for less than 48 hours and in most cases 
had only one circuit culture. Group IB was made 
up of patients who were on ventilatory support for at 
least 48 hours and who had two or more circuits 
cultured. 
+ Fisher's exact test (2-tail) 
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Table 27. Culture Results from Circuits in Group IA 
* 
and Group IB: Pathogens versus Absence of Pathogens 
Source of 
Culture 
Group IA Group IB 
Pathogen Pathogen P value# 
Absent/Present Absent/Present 
Circuit cultures 
(all components) 
21 5 217 343 0. 00009 
Circuit cultures 
(internal surfaces) 
22 4 231 329 0. 00009 
Condensate 18 3 299 240 0. 006 
Humidifier Water 21 0 520 7 1. 00 
Air cultures 17 
(Andersen air sampler) 
1 457 54 0. 71 
1st stage only 17 1 464 44 1. 00 
2nd stage only 17 0 486 20 1. 00 
• Group IA was made up of patients who were on the 
ventilator for less than 48 hours and in most cases had 
only one circuit culture. Group IB was made up of 
patients who were on ventilatory support for at least 
48 hours and who had two or more circuits cultured. 
+ Fisher's exact test (2-tail) 
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compared. It can be seen in Table 27, where only pathogenic 
isolates are compared, that the differences between Group IA 
and Group IB are even greater. Also, when cultures of 
condensate that yielded pathogens are compared, it can be 
seen that cultures from Group IB are significantly more 
likely to be positive. Since Group IB circuits were 
significantly more likely to be culture positive than Group 
IA circuits, only data from Group IB circuits were used for 
comparison of circuits changed at 24 hours and circuits 
changed at 48 hours. 
Microbial Contamination of Circuits Changed at 24 Hours 
versus Circuits Changed at 48 Hours. Results of this 
analysis are presented in Tables 28 and 29. As can be seen 
in Table 28, there were no significant differences in the 
results of any cultures taken from circuits in Group I and 
Group II. The only significant difference between Group I 
and Group II with respect to the presence of pathogens was 
in the air cultures. Although there was a significantly 
higher percentage of positive air cultures in circuits 
changed at 48 hours, the difference for stage 1 cultures was 
of borderline significance and the difference between Group 
1 and Group II in the stage 2 air cultures was not 
significant. These results indicate that there is no 
important difference between the results of air cultures 
from Group I and Group II. Only viable particles from stage 
2 can reach the lower respiratory tract. Since there was no 
significant difference in stage 2 cultures, it can be 
concluded that changing circuits at 48 hours places the 
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* 
Table 28. Culture Results from Circuits in Group I 
and Group II: Positive Cultures versus Negative Cultures 
Source of 
Culture 
Group I 
Microbial growth 
Absent/Present 
Group II 
Microbial growth P value+ 
Absent/Present 
Circuit cultures 
(all components) 
33 527 21 313 0. 88 
Circuit cultures 
(internal surfaces) 
64 496 30 304 0. 26 
Condensate 142 397 76 236 0. 57 
Humidifier water 511 16 295 10 0. 84 
Air cultures 235 
(Andersen air sampler) 
276 137 146 0. 55 
1st stage only 252 256 152 129 0. 23 
2nd stage only 364 142 210 68 0. 31 
* Data for Group I in this table are the same as the data 
from Group IB described in the previous section and 
shown in Tables 26 and 27. 
+ Fisher's exact test (2-tail) 
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* 
Table 29. Culture Results from Circuits in Group I 
and Group II: Pathogens versus Absence of Pathogens 
Source of Group I Group II 
Culture Pathogen Pathogen P value+ 
Absent/Present Absent/Present 
Circuit cultures 
(all components) 
217 343 113 221 0. 15 
Circuit cultures 
(internal surfaces) 
231 329 118 216 0.09 
Condensate 299 240 163 149 0.39 
Humidifier water 520 7 298 7 0.40 
Air cultures 457 
(Andersen air sampler) 
54 239 44 
o
 
o
 
1st stage only 464 44 244 37 0.05i 
2nd stage only 486 20 259 19 0.09 
* Data for Group I in this table are the same as the data 
from Group IB described in the previous section and shown 
in Tables 25 and 26. 
+ Fisher's exact test (2-tail) 
101 
patient at no greater risk that changing circuits 
hours. 
DISCUSSION 
Thirty-five of 211 patients (16.630 developed pneumonia 
during my study. There is very little published data with 
which to compare this rate. In the SENIC study, Hooten and 
co-workers (41) reported infection rates by level of risk. 
From the lowest level of risk, stratum 1, the infection rate 
was 0.02% and from the highest level of risk, stratum 9, the 
infection rate was 15.3%. In this report, ventilatory 
support was not examined as a risk factor. The only other 
published study that evaluated patients on ventilatory 
support was that of Craven and co-workers (20). Twenty-one 
percent of their artificially ventilated patients developed 
pneumonia. Thus, the rate of 16.6% in my study was similar 
to that of Craven and co-workers. 
Although no definitive studies have evaluated 
ventilatory support as a risk factor for pneumonia, it would 
appear that this type of therapy places persons at high risk 
of pneumonia. To date, only one study has examined 
ventilatory support as a risk factor. This study, by 
Stevens and co-workers (96), was retrospective and there was 
difficulty in determining when pneumonia occurred with 
respect to when the patient was placed on controlled 
ventilation. Although never proven in a prospective, 
epidemiologic study, artificial ventilation would appear to 
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be an important risk factor for pneumonia since my rate and 
that of Craven and co-workers were both higher than the rate 
in the highest risk stratum from the CDC SENIC study (41). 
More than one half (56%) of the patients developed 
tracheobronchitis while on ventilatory support. To my 
knowledge, this is the first study to define the rate of 
tracheobronchitis in patients on artificial ventilation. It 
is unclear as to why patients on respirators have a rate of 
tracheobronchitis that is nearly four times that of 
pneumonia. It is also unclear as to whether 
tracheobronchitis and pneumonia have a similar pathogenesis. 
It would be interesting to speculate that tracheobronchitis 
is a precursor of pneumonia in ventilated patients. This is 
suggested by the observations that tracheobronchitis occurs 
at a mean time three days earlier than pneumonia, while the 
pathogens isolated from patients with tracheobronchitis are 
the same as those isolated from patients with pneumonia. 
Changing ventilator circuits at 24 or 48 hours was not 
related significantly to occurrence of pneumonia (13* versus 
21.1%, respectively, p = 0.14). Whether circuits were 
changed at 24 or 48 hours also had no significant impact on 
the rate of tracheobronchitis (58.6% versus 52.6%, p = 
1 . 0 0 )  .  
When patients were randomized to 24 or 48 hour circuit 
changes, there were significant differences in two of the 54 
characteristics examined. One of these factors was chest 
injury. As will be seen below, I found that chest injury 
was a risk factor for pneumonia. Patients randomized to 48 
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hour circuit changes were significantly more likely to have 
chest injury. This risk factor would tend to increase the 
infection rate in Group II. In spite of this increased risk 
for Group II patients, there was no significant difference 
in infection rates between Group I and Group II. Patients 
in Group II also had a significantly higher number of 
patients receiving antacids. Although I did not find 
antacids to be a risk factor for infection in this 
population, duMoulin, Craven and Donowitz (28,20,27) found 
that administration of antacids was a risk factor for 
pneumonia. Once again, however, in spite of a potentially 
higher risk of infection in Group II patients, there was no 
significant difference in infection rates between patients 
having their circuits changed at 24 hours or 48 hours. 
I analyzed the risk factors for pneumonia using two 
different approaches. In the first approach, patients with 
pneumonia were analyzed versus all other patients without 
pneumonia. Because the latter group contained patients with 
tracheobronchitis, and therefore would tend to make this 
group more like the infected group, I decided that a second 
analysis should be carried out in which patients with 
pneumonia were compared to patients with no respiratory 
infections. 
In the first analysis, where patients with pneumonia 
were compared with patients without pneumonia, five risk 
factors for pneumonia were identified. These five factors 
included head injury, chest injury, surgical operation other 
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than cranial, thoracic or abdominal, being hospitalized in 
the neurosciences ICU, and duration of ventilation. Having 
received antibiotics and having been intubated by the 
nasotracheal route appeared to protect against development 
of pneumonia, and absence of each of these factors could be 
considered a risk factor. 
The only published prospective study in patients on 
controlled ventilation is that by Craven and co-workers 
(21). The only risk factors for pneumonia in patients on 
controlled ventilation, identified both by me and Craven and 
co-workers, were head injury and not having received 
antibiotics during assisted ventilation. Four other 
variables that I identified as risk factors, including chest 
injury, absence of a nasotracheal tube, location in the 
neurosiences ICU, and other types of surgery, were not 
examined by Craven and co-workers nor, to my knowledge, in 
any other published studies. 
As in the study of Craven and co-workers, I also 
examined intracranial pressure monitoring, craniotomy, 
treatment with cimetidine, timing of circuit changes, 
Winter-Fall season of ventilation (September 21-March 21), 
and coma. I did not find any of these factors to be risk 
factors for pneumonia. Failure to identify coma as a risk 
factor in my study may have been due to the very low numbers 
of patients with coma when head injury patients were 
excluded. Except for ventilation in the Winter-Fall season, 
I am unable to determine why Craven and co-workers showed 
these latter characteristics to be risk factors and I did 
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not. With respect to ventilation in the Winter-Fall season, 
this may have been a risk factor for patients at Boston City 
Hospital where there may have been a higher proportion of 
indigent patients and where the winters were more severe. 
Stepwise logistic regression analysis of my data 
revealed that the most powerful predictors of ventilator-
associated peumonia were duration of ventilation, never 
having reveived an antibiotic and having had a chest injury. 
These results of multivariate analysis are very different 
from those of Craven and co-workers. However, the only 
variable common to the models for logistic regression in my 
study and that of Craven and co-workers was head injury. 
Although the latter authors found that not having received 
an antibiotic was a risk factor for pneumonia by univariate 
analysis, they did not include this variable in their model 
for logistic regression analysis. Unlike Craven and 
co-workers, I found that duration of ventilation, not having 
reveived an antibiotic and presence of chest injury were 
more powerful predictors of pneumonia in patients on 
controlled ventilation than presence of head injury. 
When patients with pneumonia were analysed versus 
patients with no infections, risk factors identified 
included head injury, treatment with pancuronium, presence 
of a tracheostomy, presence of a ventriculostomy, a 
prolonged duration of ventilation, and hospitalization in 
the neurosciences ICU. Again, treatment with antibiotics 
and presence of a nasotracheal tube were protective against 
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pneumonia. If the absence of the latter two factors are 
considered risk factors, then eight risk factors were 
identified in this analysis. In the first analysis, chest 
injury and other types of surgery were risk factors for 
infection, but these factors were not associated with a 
significantly increased risk of infection in the second 
analysis. It is unclear why other types of surgery dropped 
out as a risk factor. Chest injury could no longer be shown 
to be a risk factor for pneumonia, because when the 
tracheobronchitis patients were removed from the patients 
without pneumonia, insufficient numbers of patients remained 
in that group to accurately access chest injury as a risk 
factor. In this analysis, treatment with pancuronium, 
presence of a tracheostomy and presence of a ventriculostomy 
were identified as risk factors, because removal of 
tracheobronchitis patients from the group of patients 
without pneumonia heightened the differences between the 
groups with and without pneumonia. As in the study of 
.Craven and co-workers (17), ventriculostomy was identified 
as a risk factor for pneumonia. 
Analysis of patients with pneumonia versus patients 
with no infection appeared to be more informative than 
analysis of patients with pneumonia versus patients with no 
pneumonia. While one important risk factor, chest injury, 
was lost in the second analysis, three new risk factors were 
identified. However, multivariate analysis of this data 
once again showed duration of ventilation, and absence of 
treatment with antibiotics to be the most powerful 
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predictors of ventilator-associated pneumonia. 
In the third analysis, patients with tracheobronchitis 
were compared with patients without infection. Only three 
risk factors could be identified for tracheobronchitis. 
These included having had any type of surgical operation, 
having had cranial surgery and having had a prolonged 
duration of ventilation. Thus, only prolonged duration of 
ventilation was a risk factor for both pneumonia and 
tracheobronchitis. I am unable to explain why cranial 
surgery and surgical operations are risk factors for 
tracheobronchitis. Cranial surgery may have been 
interrelated with the effects of ventriculostomy and 
administration of pancuronium, both of which had a 
borderline significant relationship with tracheobronchitis. 
Patients who had cranial operations frequently had 
ventriculostomies and were frequently treated with 
pancuronium. However, multivariate analysis showed that 
only duration of ventilation was a strong independent 
predictor for the occurrence of tracheobronchitis. 
Sixty-three percent of cultures from breathing circuits 
were positive for pathogens. The culture positivity rate in 
my study was higher than that observed by Craven and co­
workers (17) of 45.5%. Craven and co-workers cultured only 
effluent gases, water from the humidifier and internal 
surfaces of the tubing with a broth washout technique. In 
addition to these cultures, I cultured condensate drained 
from the tubing, and internal surfaces of the ends of the 
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tubing and Y-connector using swabs. 
There are few data in the literature on microorganisms 
that contaminate ventilator circuits. The only report with 
which to compare my data is that of Malecka-Griggs and 
Reinhardt (59). The only microorganism isolated by these 
authors that was not isolated from circuits in my study was 
El&vpbacter ium nieningosepticum. On the other hand, I 
isolated eleven species not recovered by these authors. 
This may have been due to the much greater number of 
circuits cultured in my study. 
Fifty-four percent of Group I air cultures and 51.6* of 
Group II air cultures were positive. These rates are nearly 
twice the rates of 30* and 32% from Group I and Group II 
patients of Craven and co-workers. My study and that of 
Craven and co-workers are not strictly comparable, because 
the ventilators were set at different flow rates. Further, 
my data were all generated using the Andersen air sampler, 
and the study of Craven and co-workers used three different 
methods including the Andersen air sampler, the Aerotest air 
sampler, and the tube-broth method for culturing 
inspiratory-phase gas. Twenty-four percent of the Group I 
air cultures and 37* of the Group II air cultures in my 
study yielded pathogenic organisms. To my knowledge, my 
study is the first to differentiate pathogenic and non­
pathogenic organisms from air cultures. It would appear 
that only a small number of the pathogenic microorganisms 
present in the circuits could be aerosolized, because the 
only pathogens aerosolized were the ones that were present 
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the greatest number of times in the circuits. I found that 
two-thirds of the pathogenic species present in air cultures 
were also present in the sputum of patients. aeruginosa 
was the most frequently isolated pathogen from air cultures 
and, interestingly, was the pathogen most commonly recovered 
from the sputum of patients with pneumonia. Craven and co­
workers also observed that pathogenic species recovered from 
inspiratory-phase-gas were also frequently isolated from the 
sputum of patients. The studies of Lareau and Craven and 
co-workers (53,17) both suggested that these pathogens 
frequently appear in sputum before they appear in 
inspiratory-phase-gas cultures. 
In this study, patients who were randomized to 24 hour 
circuit changes (Group I), but who were on the ventilator 
for less than two circuit changes, were not used for 
comparison of infection rates between Group I and Group II 
patients. These patients were excluded from analysis of 
Group I and Group II infection rates, because they would 
have all been exposed to the ventilator for less time than 
any person randomized to 48 hour circuit changes. The 
results of the analysis of patients randomized to 24 hour 
circuit changes where cultures from the group who were on 
the ventilator for less than two circuit changes (Group IA-
Tables 26 and 27) were compared with the cultures from the 
group who were on ventilation for two or more changes (Group 
IB-Tables 26 and 27), showed several significant differences 
between these two groups. Thus, when positive versus 
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negative cultures were examined (Table 26), it was seen that 
circuits in general and internal surfaces of circuits were 
significantly more likely to be positive in Group IB than in 
Group IA. Similarly, when only recovery of pathogens was 
examined, it could be seen that cultures of circuits in 
general, internal surfaces of circuits, and condensate were 
significantly more likely to have been positive in Group IB 
than in Goup IA (Table 27). The observation that the 
circuits in Group I that were used at the beginning of 
ventilation, and in many instances early in hospitalization, 
were significantly less likely to be culture positive than 
those circuits changed at 24 hours later in the course of 
controlled ventilation supported the observations of others 
(53,20) that circuits were frequently contaminated by the 
patients themselves. Thus, it would appear that the longer 
patients were on the ventilator and in the hospital, the 
more likely they would have been colonized with nosocomial 
pathogens and the more likely they themselves would have 
contaminated the circuits used later . in the course of 
ventilation. These data also supported the exclusion of 
patients from Group I who were randomized to 24 hour circuit 
changes but who were on ventilation for less than two 
circuit changes prior to the comparison of infection rates 
in Group I and Group II. Patients who were randomized to 
the 24 hour circuit changes and who were on the ventilator 
for less than two circuit changes would have been likely to 
skew the infection rate in Group I, because they represented 
a subgroup less likely to be colonized with pathogens and 
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less likely to develop HAP. 
The results of the cultures of Group I and Group II 
circuits supported the observation from the epidemiologic 
portion of the study that there was no difference in 
infection rates between patients whose circuits were changed 
at 24 hours and patients whose circuits were changed at 48 
hours. When one examines the data from Table 28 (Positive 
Cultures versus Negative Cultures) and the data from Table 
29 (Pathogens versus Absence of Pathogens), it can be seen 
that there were only two significant differences in cultures 
from Group I and Group II. Pathogens were significantly 
more likely to be isolated from the air cultures of patients 
in Group II. This difference was likely due to the 
significantly higher percentage of stage 1 air cultures in 
patients in Gr up II that were positive. However, the stage 
1 cultures are not indicative of a significantly greater 
risk of infection in Group II patients. First, stage 1 
cultures were less precise than stage 2 cultures, because 
15-20% were contaminated by condensate. Second, particles 
carrying microorganisms that are trapped in stage 1 are too 
large to reach the lower respiratory tract. When culture 
data from stage 2, the only stage that measures numbers of 
respirable particles, are considered, it can be seen that 
there is no significant difference between Group I and Group 
II. The microbiological data from this study confirm the 
observation of Craven and co-workers (20). 
In summary, the epidemiological and microbiological 
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data from this study corroborates the studies of Craven and 
co-workers (17,20). However, I identified risk factors for 
ventilator-associated pneumonia that have not been reported 
previously in the literature. These included duration of 
ventilation, the most powerful predictor for occurrence of 
pneumonia and tracheobronchitis, presence of chest injury, 
and administration of pancuronium. Although previously 
reported by Craven and co-workers (20), not having received 
antibiotics was the second most powerful predictor of 
pneumonia after duration when the data were analyzed by 
logistic regression analysis. 
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Admission Date _ 
Patient died y Yes 
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(26)  
Age (24, 25) 
Sex: m. Male 
f._ Female (27) 
Smoking: p. Past 
c. Current 
n. Never (29) 
Race: b. Black 
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o. Other 
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(36-40) [x] _ 
(41-45) [x] _ 
(46-50) [x] 
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b . Bronchiectasis (57) 
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c . Chronic renal failure 
d . Neoplastic disease 
e . Hypertension 
f . Etanol abuse 
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r i (42-44) , / , / , 
t  i (57-59) 
Dup Columns 1-9 
1 I (12-14) , / , / . 
1 1 (27-29) , / , / , 
• t (42-44) 
I 1 (57-59) 
Dup Columns 1-9 
t 1 (12-14) 
1 1 (27-29) , 1 , 1 ,  
t I (42-44) , 1 , 1 ,  
1 f (57-59) , 1 , 1 ,  
Dup Columns 1-9 
» 1 (12-14) , 1 , 1 ,  
1 I (27-29) , 1 , 1 ,  
t 1 (42-44) , 1 , 1 ,  
1 | (57-59) , 1 , 1 ,  
Dup Columns 1-9 
I 1 (12-14) , 1 , 1 ,  
' » (27-29) , 1 , 1 ,  
f I (42-44) , 1 , 1 ,  
1 I (57-59) , 1 , 1 ,  
(15-20) 
(30-35) 
(45-50) 
(60-65) 
(15-20) 
(30-35) 
(45-50) 
(60-65) 
(15-20) 
(30-35) 
(45-50) 
(60-65) 
Date Stopped 
(15-20) 
(30-35) 
(45-50) 
(60-65) 
A,5 I 
(15-20) 
(30-35) 
(45-50) 
(60-65) 
, 1 , 1 ,  (21-26) [x] 
, 1 , 1 ,  (36-41) [x] 
, 1 , 1 ,  (51-56) [x] 
, 1 , 1 ,  (66-71) [x] 
, ID 
, 1 , 1 ,  (21-26) [x] 
, 1 , 1 ,  (36-41) [x] 
, 1 , 1 ,  (51-56) [x] 
, 1 , 1 ,  (66-71) [x] 
. ID 
, 1 , 1 ,  (21-26) [x] 
, 1 , 1 ,  (36-41).[x] 
, 1 , 1 ,  (51-56) [x] 
, 1 , 1 ,  (66-71) [x] 
, ID 
, 1 , 1 ,  (21-26) [x] 
, 1 , 1 ,  (36-41) [x] 
, 1 , 1 ,  (51-56) [x] 
, 1 , 1 ,  (66-71) [x] 
, 1 , 1 ,  (21-26) [x] 
, 1 , 1 ,  (36-41) [x] 
, 1 , 1 ,  (51-56) [x] 
, 1 , 1 ,  (66-71) [x] 
Adm Circuit 
# # 
(1-11) I 0,1 I (12, 13) 126 
OPERATIONS 
Operation Date 
(ICD9-CM) 
(14-18) 1 , 1 ,  1 (19-24) [x] 
Type of Operation 
Region of incision: a. 
c. 
(25) t. 
Abdominal 
Cranial 
Thoracic 
Other 
Anesthesia: g. General 
(26) l._ Local 
s. Spinal 
Duration of operation 
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Operation Date 
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VENTILATION 
Patient's Name [x] 
Date Time 
Breathing circuit started , / , / , l • 1 (14-23) 
stopped , / . / , I • 1 (24-33) 
Technical change of 
ventilator: 
c._circ. change 
ri.__tenio.riisc. 
n. none 
Location (where breathing circuit was started 
and where it was maintained): 
m. GMICU (35) 
s. GSICU (36) 
n. NSICU (37) 
c. CICU (38) 
r. RICU (39) 
Dup columns 1-11 I V,2 1 (12, 13) 
Intubation Date Started Date Stoooed 
(14) o. Oral-tracheal •./,/, (15-20) (21-26) 
(27) n. Naso-tracheal , / , / , (28-33) (34-39) 
(40) b. Bronchoscopy (41-46) (47-52) 
(53) t .  Tracheostomy (54-59) (60-65) 
(65) 1. Lung biopsy (67-72) 
a . Percutaneous aspiration 
b . Transbronchial biopsy 
c . Open lung biopsy 
(73) 
Purulent sputum noted: y. (74) 
00 
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Type # Name 
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(1 -12)  / / 
Q. Date Culture Taken 
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Counts 
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CULTURES 
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X 0 
X 0 
X 0 
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X 0 
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I<1-?> I  < 1 0 ,  1 1 )  
A  d m  #  
S E P T I C E M I A  
S E P T I C E M I A  i s  d e f i n e d  b y :  
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2 )  c h i l l s  
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RESPIRATORY INF 
PNEUMONIA is defined by: 
a. appearance of purulent sputum 
b. appearance of new or progressive infiltrate on CXR 
c. respiratory secretions positive or negative for organisms 
Date of Diagnosis Organisms 
/ / (12-17) [ x ]  
[ x ]  
[x]  
( 18, 23 
(  2 U ,  2 $  
( 30, 33 
Please call Archer Lamb, Beeper 718, when a positive diagnosis occurs. 
TRACHEOBRONCHITIS is defined by: 
a. appearance of purulent sputum 
b. stable or absent pulmonary infiltrate on CXR 
c. respiratory secretions positive or negative for organisms 
Date of Diaancsis 
i / 
Organisms 
(36,M) Ix] 
[ x ]  
[ x ]  
&2,- bl ) 
& 8 ,  5 3 )  
feh, 59 ) 
No respiratory tract infection: y. (60^ 
Date patient exits study 
(72 hours after ventilator 
discontinued) 
/ / (61,66) 
